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ABSTRACT

STRUCTURAL CHARACTERIZATION OF THE INTEGRIN αIIbβ3
TRANSMEMBRANE AND CYTOSOLIC DOMAINS
Douglas G. Metcalf

William F. DeGrado
Integrin’s are the principal cell surface receptors that link the cytoskeleton to the
extracellular matrix. They exist in active conformations that can bind extracellular
ligands and resting conformations that cannot. The platelet integrin αIIbβ3 is a
prototypical regulated integrin that is resting on a circulating platelet and
becomes activated to adhere the platelet to the vascular endothelium or
subendothelial matrix.
The integrin is composed of α and β subunits and each subunit contains a
single transmembrane helix that form an α/β heterodimer in the resting state.
Additionally, each subunit contains a cytosolic domain that binds signaling
proteins that affect the resting-active equilibrium.

Activation signals are

transduced across the membrane by separating the transmembrane heterodimer.
The structure of the resting integrin αIIbβ3’s transmembrane and cytosolic
domains was characterized by molecular modeling and NMR spectroscopy.
First, software was developed to model transmembrane helix dimers using
iii

experimental mutagenesis results as a modeling restraint.

Next, the αIIb/β3

transmembrane heterodimer was modeled and the model was compared to
published experimental data and other published models. The model correlated
well with experimental findings and converged on the same structure as other top
performing models, suggesting this conformation approximates the native
interface. The model’s interface includes αIIb residue Met987 and β3 residue
Leu712.

These residues were mutated to cysteine to crosslink peptides

corresponding to the αIIb and β3 cytosolic tails, and the disulfide-linked construct
was probed by NMR spectroscopy.
NMR revealed that the αIIb and β3 cytosolic tails have a dynamic
interface. The αIIb subunit is natively unstructured and the β3 subunit consists of
a hydrophobic helix followed by two amphiphilic helices.

The amphiphilic

portions of β3 include domains that interact with cytosolic proteins, but the
membrane embedding of its hydrophobic faces sequesters some of the
interacting residues.

This result suggests that the integrin’s resting-active

equilibrium is coupled to an equilibrium between membrane embedded and
solvent exposed conformations of the β3 cytosolic tail, providing new insight into
integrin activation.

iv

TABLE OF CONTENTS

CHAPTER 1
Background on Integrins and Methods to Define Their
Three-Dimensional Structure
Introduction. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

1

CHAPTER 2
Development of Software to Model the Integrin
αIIb/β3 Transmembrane Heterodimer
Introduction. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

8

Materials and Methods. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

11

Results. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

19

Discussion and Conclusions. . . . . . . . . . . . . . . . . . . . . . . . . .

26

CHAPTER 3
Multiple Approaches Converge on the Structure of the Integrin
αIIb/β3 Transmembrane Heterodimer
Introduction. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

37

Materials and Methods. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

39

Results. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

46

Discussion and Conclusions. . . . . . . . . . . . . . . . . . . . . . . . . .

57

v

CHAPTER 4
Structural Characterization of a Disulfide-Linked αIIb/β3 Cytosolic Domain
Introduction. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

73

Materials and Methods. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

78

Results. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

84

Discussion and Conclusions. . . . . . . . . . . . . . . . . . . . . . . . . .

99

CHAPTER 5
Discussion, Future Direction, and Concluding Remarks
Discussion. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

115

LIST OF TABLES
I

Glycophorin A and BNIP3 mutations used as inputs for the Monte Carlo

modeling algorithm. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
II

Sequences of glycophorin A homologs, orthologs, and single nucleotide

polymorphisms. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
III

Qualitative comparison of six αIIb/β3 models with experimental findings

and the structural similarity of these models reported as Cα RMSD. . . . . . . . . 52
IV

Structural similarity between top performing models and two models that

are currently in press, reported as Cα RMSD. . . . . . . . . . . . . . . . . . . . . . . . . . 63
V

NMR structure statistics. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 95
vi

LIST OF FIGURES
1

Energy landscapes for the glycophorin A transmembrane dimer. . . . . . 13

2

Flow chart for the Monte Carlo modeling algorithm. . . . . . . . . . . . . . . . . 16

3

Graphical representations of the penalties used to score models. . . . . . 22

4

Models of glycophorin A fit to its NMR structure. . . . . . . . . . . . . . . . . . . 24

5

The model of glycophorin A generated with sequence homology data is

nearly identical to a structure in the glycophorin A NMR ensemble. . . . . . . . . . 24
6

Model of BNIP3 and its sequence. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25

7

Cartoon of the equilibrium between resting and active integrins. . . . . . . 38

8

Sequences of the αIIb and β3 transmembrane domains. . . . . . . . . . . . . 40

9

Monte Carlo model of the αIIb/β3 heterodimer depicting qualitative

agreement with experimental mutagenesis results. . . . . . . . . . . . . . . . . . . . . . .48
10

Slices through the Monte Carlo αIIb/β3 model depicting qualitative

agreement with experimental cysteine crosslinking results. . . . . . . . . . . . . . . . 49
11

Graphical representation of the quantitative correlations between different

αIIb/β3 TM models and experimental mutagenesis results. . . . . . . . . . . . . . . . 54
12

Graphical representation of the quantitative correlations between different

αIIb/β3 TM models and experimental cysteine crosslinking results. . . . . . . . . . 56
13

Structural comparison of different models for the resting αIIb/β3

transmembrane heterodimer. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 61
14

Sequence and topology of the disulfide-linked αIIb/β3 NMR construct. . 76
vii

LIST OF FIGURES (continued)
15

SDS-PAGE analysis of the disulfide-linked αIIb/β3 NMR sample. . . . . . 82

16

Circular dichroism analysis of the disulfide-linked αIIb/β3 construct and its

component monomers. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 86
17

Analysis of β3 Cα chemical shifts in the disulfide-linked heterodimer and

a β3 monomer. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .88
18

13

C HSQC spectra for the disulfide-linked heterodimer and its component

monomers. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 89
19

H-15N NOE intensities in the disulfide-linked heterodimer. . . . . . . . . . . . 91

20

15

N HSQC spectra for the disulfide-linked heterodimer before and after

hydrogen-deuterium exchange. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 93
21

NMR structure of the β3 subunit in the disulfide-linked heterodimer

depicting interfaces that interact with αIIb, talin, kindlin-3, and Src kinase. . . . .96
22

Cartoon of the calculated membrane embedding for portions of the β3.

subunit. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 100
23

Cartoons that illustrate the β3/talin interaction. . . . . . . . . . . . . . . . . . . . 105

viii

LIST OF EQUATIONS
1

Scoring function used to penalize the calculated energy of a modeled

conformation that is inconsistent with experimental mutagenesis results. . . . . 21
2

Function used to calculate penalties for modeled conformations that are

inconsistent with one or more disruptive mutations. . . . . . . . . . . . . . . . . . . . . . 21
3

Function used to calculate penalties for modeled conformations that are

inconsistent with one or more neutral mutations. . . . . . . . . . . . . . . . . . . . . . . . 22
4

Equation used to correlate the calculated Cβ-Cβ distances in a model

with experimentally determined cysteine crosslinking yields. . . . . . . . . . . . . . . 44
5

Equation used to calculate a residue’s fractional change in solvent

accessible surface area fASA upon dimerization. . . . . . . . . . . . . . . . . . . . . . . . . 45

ix

CHAPTER 1

Background on Integrins and
Methods to Define Their Three-Dimensional Structure

INTRODUCTION
Integrins are cell surface receptors that enable cell-cell and cell-matrix
interactions by engaging extracellular molecules. Integrin-ligand binding events
mediate cell adhesion and migration and initiate intracellular signaling pathways
that regulate key processes such as proliferation, differentiation, and apoptosis.1
Thus it is not surprising that integrins play pivotal roles in health and disease.
For example, they are targeted by snake venoms, including rattlesnake and
cottonmouth venoms that can cause hemorrhage and occasionally death.2
Additionally, viruses including adenovirus, rotavirus, hantavirus, and HIV
recognize integrins to penetrate and hijack cells.3 In the research and clinical
setting, integrins serve as biomarkers to distinguish different cell types and
they’re used for diagnostics to characterize pathological states.4 Also, various
pharmaceuticals target integrins in approved treatments for multiple sclerosis,
Crohn’s disease, and certain coronary events (TysabriTM generated $589 million
1

in revenue for 2008),5;

6

and integrin antagonists are being developed as

therapeutics for other conditions such as cardiovascular disease and cancer, the
number 1 and 2 leading causes of death in America.6; 7; 8 Thus integrin structure
and function is an intriguing and important field of study in biology and medicine.
Integrins are transmembrane (TM) glycoproteins composed of α and β
subunits.

In mammals, there are 18 different α subunits and 8 different β

subunits that form 24 known α/β pairs through a heterodimeric interaction in their
extracellular domains.1 Each integrin subunit is a type 1 membrane protein that
also contains a single TM helix and a cytosolic carboxy-terminus. The plasma
membrane contains α/β heterodimers that exist in an equilibrium between resting
conformations that have low affinity for extracellular ligands and active
conformations that have high affinity.9 Signaling cascades that shift the integrin
equilibrium toward the active state, termed “inside-out” signals, have received
significant attention over the past few decades, including the recent identification
of the cytoskelatal proteins talin and kindlin as essential mediators of integrin
activation.10;

11

These molecules are postulated to bind the integrin’s cytosolic

domains and disrupt a heterodimeric α/β interaction in the TM region. Separation
of the resting integrin’s α/β TM heterodimer functions to transduce an activation
signal across the membrane, ultimately causing a conformational change that
exposes the integrin’s extracellular ligand binding sites.12 Once an integrin is
activated, it can initiate “outside-in” signals and recruit additional proteins to form
large structural and signaling complexes such as focal adhesions that tightly bind
2

the underlying actin cytoskeleton.13 The goal of the research presented here is to
test hypotheses that suggest mechanisms for integrin activation by defining the
three-dimensional structure of the resting integrin’s TM and cytosolic domains.
Three-dimensional models of protein structure are invaluable research
tools because they provide paradigms to predict and validate experimental
results, and their importance is underscored by the $765 million Protein Structure
Initiative.14 For integrins, three-dimensional structures of the extracellular domain
in “bent” and “extended” conformations led to several testable hypotheses that
suggest different mechanisms for integrin activation.15; 16; 17 Additionally, models
of the integrin’s TM and cytosolic domains have been developed, however until
recently, they provided marginal insight into integrin function because they did
not make useful predictions or spur further analysis.
This thesis describes and authenticates a model of the resting TM
heterodimer for the αIIbβ3 integrin that aided in the engineering of a disulfidelinked αIIb/β3 cytosolic domain. The model was calculated using a recentlydeveloped Monte Carlo algorithm that includes a selective advantage for
conformations that are consistent with experimental mutagenesis results, and
this software is benchmarked and validated in chapter 2. The Monte Carlo model
was subsequently confirmed by measuring several of its attributes and
correlating them with published experimental results using other published
models as controls, and chapter 3 presents this analysis.

Correlations with

cysteine crosslinking experiments were of particular interest because they
3

identified αIIb/β3 cysteine mutant pairs at the model’s heterodimer interface that
could covalently crosslink the αIIb and β3 subunits.18 Based on this finding,
cysteines were positioned to enforce the model’s TM heterodimer interface in a
construct consisting of the αIIb and β3 cytosolic domains tethered by a disulfide
bond.

This construct was expressed, purified, and then probed by NMR

spectroscopy, enabling the calculation of a solution structure for the β3 subunit
described in chapter 4.

The subsequent structural analysis makes several

predictions that weren’t apparent a priori.

Notably much of the β3 cytosolic

domain is pre-organized into conformations that are similar to structures depicted
in β3/talin interfaces,19; 20 thereby minimizing the entropic cost of binding, however
these regions are calculated to partition into the plasma membrane and an
interaction with talin would trap β3 in an alternate, exposed conformation,
providing a mechanism for talin-induced conformational change.

Further

implications of the NMR structure and future directions are discussed in chapters
4 and 5.
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CHAPTER 2

Development of Software to Model the Integrin
αIIb/β3 Transmembrane Heterodimer

INTRODUCTION
The prediction of membrane protein structure is a particularly important endeavor
given the relative difficulty of determining structures experimentally.

Despite

impressive progress in the development of force fields and energy scoring
functions,1;

2; 3; 4

current modeling protocols cannot reliably identify the native

conformation of most membrane proteins without additional information from
experimental analysis.

Successful protocols exploit information derived from

sequence analysis,5; 6; 7; 8; 9; 10 spectroscopy,5; 8; 9; 11; 12; 13; 14 cross-linking,8; 11; 12 and/or
mutagenesis,8; 15; 16 or the known structures of homologous17 or non-homologous
proteins.1
Brunger and coworkers developed a conformational searching algorithm to
predict membrane helix oligomers, and this protocol has been applied to
glycophorin A,15;

18

phospholamban,19 the M2 and CM2 proton channels in the

influenza A and C viruses,20 and the vpu protein from HIV-1.20 In this protocol,
conformational space is searched exhaustively and then low energy structures
8

are screened to identify conformations that are most consistent with experimental
findings,

frequently

mutagenesis

results.

Alternatively,

orthologous

or

homologous proteins can be modeled in parallel and the native conformation can
be identified from the intersection of low energy structures generated for each
ortholog/homolog.6; 7 Briggs et al. demonstrated that this approach will identify
the native conformation of glycophorin A.7
The above methods use mutagenesis and phylogenetic information to
identify correctly modeled conformations after an exhaustive computational
search. Our methods use mutagenesis or phylogenetic information to simplify
the computational search.

Prior modeling efforts provide precedent for this

approach. Most membrane protein modeling protocols, including the protocols
described above, simplify their computational search by only considering
conformations with α-helical secondary structure. Non-helical conformations can
be excluded with structural restraints that maintain appropriate distances
between the hydrogen bonding partners in an α-helix. The structural restraints
are enforced by a term in the energy function which is analogous to the energy
function that enforces distances predicted by NMR spectroscopy.

Similar

structural restraints can enforce tertiary or quaternary structure predicted by
spectroscopy, crosslinking, mutagenesis, and/or sequence analysis.5; 8; 11; 12; 13; 14
In contrast with structural restraints which enforce distances and angles, we use
thermodynamic restraints which enforce relative differences in energy for an
ensemble of mutations.

9

During each docking step of a Monte Carlo simulated annealing cycle, we
compute the difference in dimerization energy ΔE between the wild type and an
ensemble of point mutations for the step’s conformation. The ΔE value should be
near zero for mutations that do not affect protein stability and function. Likewise,
we expect an unfavorable ΔE for destabilizing mutations. Conformations with
computed ΔE values that are inconsistent with experimental findings are
penalized by increasing their computed energies. Thus our modeling protocol
creates a selective advantage for models that are consistent with experimental
mutagenesis results.
We optimized our structure prediction protocol to study self associating
transmembrane (TM) helices. Self associating TM helices are widespread and
play vital functional and structural roles such as in the T cell receptor,21 the M2
proton channel,22 and phospholamban.23 For reviews see Engelman et al.24 and
Senes et al.25 We calibrated our structure prediction protocol with glycophorin A
(GPA), a small, well-characterized protein that dimerizes along two TM helices.
We applied our structure prediction protocol to the TM region of BNIP3 because
several labs were working to determine its NMR structure which could validate
our modeling protocol. Both GPA and BNIP3 contain GXXXG motifs.26; 27 The
GXXXG motif is the most overrepresented sequence motif found in TM helices28
and presents a strong dimerization signal.29 The motif consists of two glycines
separated by three amino acids.

The glycines enable close contact which

permits Cα-H•••O hydrogen bonding between helix backbones.30; 31 Cα-H•••O

10

hydrogen bonds, which are found in many proteins, may be important for
stabilizing membrane proteins.
Previously, our lab derived a conceptual basis for structure prediction
guided by mutagenesis data using lattice models.32

Mutagenesis data can

compensate for the limitations of a force field while permitting a significant
increase in modeling speed. Here we extend the approach to the docking of TM
helices, and we use the method to predict a molecular model for the TM region of
the BNIP3 apoptosis factor which was subsequently validated by an experimental
NMR structure.33

MATERIALS AND METHODS
Potential Function
We define dimerization energy Edimerization as the potential energy of two helices in
a docked conformation minus the energy of the two helices separated by 100 Å.
Potential energies were calculated in vacuo with the AMBER united-atom force
field for van der Waals interactions.34

We softened the potential function to

mitigate artifacts from rigid body docking. Favorable van der Waals interactions
were calculated with a 12-6 Lennard-Jones potential in which the van der Waals
radii were scaled to 95%.

Unfavorable van der Waals interactions were

dampened using a linear repulsive term with a 10 kcal per mole maximum
repulsion.35

11

Calibration
We calibrated our scoring function with glycophorin A’s (GPA) published structure
and mutational data.26;

36

10,000 GPA helix-helix dimer pairs with computed

dimerization energies less than –10 kcal per mole were generated during ten
Monte Carlo simulated annealing (MCSA) cycles similar to the MCSA protocol
described below. A plot of these structures is shown in figure 1a. Our scoring
function was parameterized to selectively penalize low energy dimers with an
RMSD greater than 1.5 Å with the GPA structure. Specifically, we averaged the
scores of the ten best scoring models with an RMSD less than 1.5 Å and the ten
best scoring models with an RMSD greater than or equal to 1.5 Å and maximized
the difference between these two averages.

Other more sophisticated

optimization methods resulted in similar parameterization. The scoring function
is described in greater detail in the results section.

MCSA Implementation
The GPA TM helices consisted of residues Ile73 through Ile95 and the BNIP3
helices consisted of residues Val164 through Gly184. A single proline occurs at
position 167 near the N-terminus of the BNIP3 helix and should not affect the
backbone geometries of downstream residues. It was modeled as alanine to
eliminate its significance relative to the method we were testing. φ, ϕ, and ω
angles were fixed at –65°, –40°, and 180°, respectively, for all amino acids.

12

Fig 1. Each graph depicts the same set of conformations plotted with a different score
on the y-axis. The arrowheads track three conformations through the graphs and do not
appear when a score is greater than 0 kcal. Native-like conformations of glycophorin A
(blue and green arrowheads) cannot be distinguished from other low energy
conformations (red arrowhead) using computed van der Waals energies (a). Penalties
can be added to the van der Waals energies of models that are inconsistent with known
disruptive mutations (b), neutral mutations (c), or both (d) to help distinguish native-like
models from non-native conformations. The penalties eliminate the non-native energy
wells at the expense of removing some conformations from the native energy well.
13

Our MCSA protocol utilizes previously characterized point mutations for
protein structure prediction. The mutants used in this analysis are listed in table
I. GPA mutants were taken from Lemmon et al.26 and BNIP3 mutants were taken
from Suljito et al.27 The GPA mutations were selected to preferentially probe the
effect of alanine and leucine scanning mutagenesis on glycine and leucine amino
acids because these mutations are commonly made and often insightful. Less
mutational data is available for BNIP3 and we used all point mutations that had
unambiguous effects. Additionally, naturally occurring sequence variation can
serve as a source of mutational information.37 Single nucleotide polymorphisms
(SNPs), orthologs, and homologs of GPA were identified with BLAST.38 Each
mismatched amino acid was scored as a neutral mutation such that each
sequence could contribute multiple neutral mutations to the analysis.
A MCSA cycle began after finding a randomly generated conformation
with a favorable dimerization energy (i.e. a dimerization energy less than zero).
A conformation is defined by the six parameters that relate two rigid helices in
space (figure 2). During each docking step of a MCSA cycle, there was an equal
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probability of changing any one parameter or all six parameters to random
values. In nine initial MCSA cycles, all possible values were allowed; the phase
of each helix θ1 and θ2 varied 360°, the crossing angle χ varied from -90° to 90°
(parallel structures only), translations along a helical axis z1 and z2 varied from –
15 to 15 Å, and the diameter d varied from 5 to 9 Å.

Fig 2 (next page). The flowchart for a global Monte Carlo simulated annealing cycle.
Idealized α-helices are docked with six orthogonal parameters: θ 1 and θ 2 are rotations of
a helix about its helical axis, χ is the crossing angle, z1 and z2 are translations of a helix
along its helical axis, and d is the distance between each helical axis. Global MCSA
cycles explore all parameter space. Subsequent MCSA cycles restrict parameter space to
the energy well defined by nine global cycles and more thoroughly explore rotamer space
(see text). Each MCSA cycle consists of 50,000 docking steps which start at box 1 and
end at box 15. The simulated annealing temperature undergoes exponential decay from
10,000 to 10 K over the 50,000 docking steps in each cycle.
15
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After docking, rotamers were set to their most common helical rotamer.
The helix-helix interface was defined by identifying residues with interaction
energies greater than 10-3 kcal per mole in magnitude. The rotamers of these
residues were optimized by Monte Carlo or dead end elimination (DEE)39 using
the Goldstein criterion40 depending on how many residues were at the helix-helix
interface. The rotamers of the monomeric states were optimized by DEE for
every residue.

Rotamers were selected from a library containing the most

common helical rotamers which consists of one to three members for each amino
acid.41
After rotamer optimization, the conformation’s dimerization energy was
calculated.

If the dimerization energy was favorable, we calculated the

dimerization energy of select point mutations. The dimerization energies were
used to calculate a score for the conformation (see equations 1-3 in the results
section). The score was used to accept or reject a conformation based on our
simulated annealing criteria. If a conformation was accepted, its six parameters
were passed to the next docking step.

If a conformation was rejected, the

parameters of the last accepted conformation were passed to the next step.
Regardless of whether a conformation was accepted or rejected, its parameters
and score were recorded to restrict conformational space in subsequent MCSA
cycles (see below). Each MCSA cycle consisted of 50,000 docking steps with an
exponential temperature decay from 10,000 to 10 K.
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MCSA, Restricted Parameter Space
Nine global, independent MCSA cycles are sufficient to define an energy well that
is consistent with an ensemble of mutations.

Afterward, parameters are

restricted to ±2 standard deviations from their mean values for structures with a
score within 10 kcal of the best structure. This typically restricts parameter space
by three orders of magnitude and allows for a fine-grained search through
conformational space. MCSA cycles were repeated as described above with
additional optimization of χ angles: rotamers were optimized with DEE for every
amino acid at the helix-helix interface and the rotamer’s χ angles were further
optimized with a grid/Monte Carlo search. Similarly, rotamers of the monomeric
states were optimized by DEE and χ angles were further optimized with a
grid/Monte Carlo search. Our figures and analyses are based on the single best
scoring models for GPA/BNIP3 that were identified during the fine-grained
search. These models are representative of the best scoring clusters.

Implementation of Penalties used to Score Mutations
The penalties used to score mutations (eq. 2 and 3 in the Results section) were
implemented to handicap the energy of each conformation that was considered
by the simulated annealing criterion. The penalties serve to artificially increase
the dimerization energy of conformations that are in poor thermodynamic
agreement with experimentally characterized point mutations. Thus a low energy
structure that does not agree with experimental findings is less likely to pass the
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simulated annealing criterion than a low energy structure that is in good
agreement with experimental findings. This provides a selective advantage for
parameters that are in good agreement with experimental results, resulting in
final models that agree well with experimental data.

BNIP3 Hydrogen Bonding
Mutational analysis of the BNIP3 TM region predicts an intermolecular hydrogen
bond involving His173.27 Our model places His173 and Ser172 in proximity but
not in contact.

The χ angles of His173 and Ser172 can be changed to

isoenergetic states that support a hydrogen bond between the His173 Nδ or Nε
and the Ser172 Oγ. No other interhelical contact can support a hydrogen bond
with His173 or Ser172.
The C-terminus of BNIP3 was not modeled because it is not embedded in
the membrane. We extended the C-terminal helix of the final BNIP3 model and
set each amino acid to its lowest energy rotamer. This positions both Thr188
residues in favorable van der Waals contact.

The geometry and distance

between the Thr188 hydroxyls predicts a hydrogen bonding interaction prior to
any optimization step.

RESULTS
An ideal structure prediction protocol would identify a native protein fold based
solely on energy calculations.

A minimal Monte Carlo simulated annealing
19

protocol that computes only van der Waals energies cannot distinguish the native
conformation of glycophorin A (GPA) from other low energy conformations (figure
1a). However the protocol is sufficient to identify low energy conformations that
are consistent with the published NMR structure. This result is similar to more
sophisticated modeling protocols which cannot distinguish the native GPA fold
from other low energy conformations without additional information.15; 18
Mutagenesis data can help distinguish the native GPA structure from other
low energy conformations. For example, residues that are important for folding,
as assessed from experimental mutagenesis studies, should lie at the helix-helix
interface of a correct model and show strong interaction energies within the
structure. Treutlien et al. reported a GPA model which has residue interaction
energies that best correlate with mutagenesis results.15; 18
To automate the process of structure prediction using mutagenesis data,
we compute the difference in dimerization energy ΔE between the wild type and
select point mutants during each docking step. The ΔE value can be compared
to experimental results to allow for the penalization of models that are
inconsistent with mutagenesis data.

In the current work we considered two

phenotypes, disruptive and neutral mutations, which have been previously
characterized

experimentally.

By

definition,

disruptive

mutations

have

unfavorable dimerization energies relative to the wild type while neutral mutations
are isoenergetic with the wild type.
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We built a scoring function to penalize conformations that are inconsistent
with known disruptive and neutral mutations.

We calculate a score for each

modeled conformation by summing its van der Waals energy and two penalties
(equation 1).

scoreconformation = E dimerization + penalty disruptive + penalty neutral

1

Edimerization is the energy of the dimer minus the energy of the monomeric state (see
!

methods).

penaltydisruptive is a restraint that creates a selective advantage for

conformations that are consistent with known disruptive mutations. penaltyneutral is
a restraint that creates a selective advantage for conformations that are
consistent with known neutral mutations.
Each disruptive mutant should have a higher computed dimerization
energy than the wild type, otherwise we penalize a conformation’s score. After
examining a number of functions, we found equation 2 to be most effective at
penalizing low energy conformations that are inconsistent with one or more
disruptive mutations. This function is plotted in figure 3a.

penalty disruptive =

" disruptive n &
)
1
ln(
,
# $%E i +
'1+ e
*
n
i=1

2

ΔEi is the computed difference in energy between disruptive mutant i and the wild
!

type protein for a given conformation. n is the total number of disruptive mutants
considered. The α coefficient scales the magnitude of the penalty and the β
coefficient shifts the curve from left to right. The optimized values used for these
coefficients are –60.1 and 0.521, respectively.

21

Fig 3. These functions penalize models that are inconsistent with a given mutation. A
disruptive mutation should have a positive ΔE (a) and a neutral mutation should have a
near zero ΔE (b). If a model is inconsistent with an experimental mutagenesis result, its
computed energy is increased by adding a normalized penalty that corresponds to the
computed ΔE for that mutant. This creates a selective advantage for models that are
consistent with mutational data.

Each neutral mutant should have a computed dimerization energy that is
comparable to the wild type. When considering GPA, we found that the optimal
scoring function penalizes models that have one or more neutral mutations with
computed stabilizing or destabilizing effects (equation 3).

penalty neutral

" neutral n # $E i
=
%e
n i=1

3

Our optimized α and β values are 1.02E-2 and 9.63, respectively.

!

We parameterized our scoring function to best penalize non-native low
energy conformations (see methods). When considering the mutations in table I,
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the scoring function creates a new energy landscape for GPA and the new global
energy minimum corresponds to the native conformation (figure 1d).

Each

conformation is penalized by one or both penalties. It is necessary to penalize
some native-like conformations in order to effectively penalize all non-native
conformations. When the scoring function is applied to our MCSA protocol, some
native-like conformations are eliminated from the analysis so that we can
eliminate every low energy non-native conformation.
We repeated the MCSA protocol for GPA with the two penalties added to
the van der Waals energy function. The best scoring model had a Cα root mean
squared deviation (RMSD) with GPA of 1.30 Å (figure 4a). This is an excellent
result considering the lowest RMSD structure accessible to our search algorithm
has an RMSD of 0.65 Å, and the TM regions of different NMR structures for GPA
vary by up to 1.80 Å. (There are twenty NMR structures for GPA in its pdb file
1AFO; we used model 1 for calibration and RMSD calculations unless otherwise
noted.)

Finally, our model recovers the Cα hydrogen bonding interactions

described by Senes et al. even though no hydrogen bonding or electrostatic term
was used to generate this model.31
Briggs et al. demonstrated that phylogenetic analysis is sufficient to
identify the native conformation of GPA.7 We repeated the MCSA protocol with
the naturally occurring sequence variants from table II. Encouragingly, the best
scoring model had an RMSD with GPA of 1.37 Å (figure 4b). This model also
recovers the Cα hydrogen bonding interactions described by Senes et al.31
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Fig 4. The glycophorin A model generated with thermodynamics data (red) fit to the
wild type backbone (green), RMSD 1.30 Å (a). The glycophorin A model generated with
naturally occurring sequence variation data (blue) fit to the wild type backbone (green),
RMSD 1.37 Å (b).

Fig 5. The glycophorin A model generated with naturally occurring sequence variation
data (blue) fit to structure 19 from the glycophorin A pdb (green), RMSD 0.54 Å. The
glycophorin A pdb file 1AFO contains twenty different NMR structures and structure 19
shows the strongest Cα-H•••O hydrogen bonding interactions. (Structure 1 was used for
calibration and all other RMSD calculations.) The two figures are related by a rotation
about the vertical axis.
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In fact, this structure has a Cα RMSD of 0.54 Å with the GPA NMR structure that
shows the strongest Cα-H•••O hydrogen bonding interactions (figure 5).
To further explore our method, we modeled the TM region of the BNIP3
apoptosis factor which also contains a GXXXG motif.

The resultant model

predicts a right-handed crossing angle of -42º and a similar conformation as
GPA. Our model accommodates an interhelix hydrogen bond between His173A
and Ser172B. The model is inconsistent with other interhelical hydrogen bonding
partners for either His173 or Ser172.

Additionally, the model is consistent with

an interhelix hydrogen bond between Thr188A and Thr188B (figure 6). Finally, it
predicts six interhelical Cα hydrogen bonds.

These include symmetrical

hydrogen bonds between the Ile177A Cα and Ala176B carbonyl, the Gly180A Cα
and Ile177B carbonyl, and the Ile181A Cα and Gly180B carbonyl.

Fig 6. Molecular model of the BNIP3 homodimer. The TM helices dimerize along
consecutive AXXXG and GXXXG motifs (red). The TM regions of the protein are
colored green and yellow, and aqueous regions are colored blue.
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DISCUSSION AND CONCLUSIONS
We developed a novel protein structure prediction strategy to model interactions
between self-associating TM helices based on experimental mutagenesis results.
The semi-quantitative determination of helix dimerization in response to
mutagenesis was sufficient for this analysis.

In the case of GPA, naturally

occurring sequence variation can substitute for mutational information to drive
structure prediction.

However we suggest that experimental mutagenesis

information be favored when available because sequence drift can be
accompanied by structural drift.

Scoring Function Analysis
Our scoring functions provide a mathematical framework for the incorporation of
experimental mutagenesis data into modeling protocols. The scoring function is
the linear combination of a van der Waals term, a penalty that evaluates
disruptive mutations, and a penalty that evaluates neutral mutations. The neutral
penalty may be less intuitive than the disruptive penalty. If a neutral mutant has
a computed destabilizing effect, we penalize the model because we expect
disruptive mutants to have computed destabilizing effects. If a neutral mutant
has a computed stabilizing effect, the interpretation is less straightforward
because stabilizing mutations are often accompanied by structural changes. For
example, many mutations stabilize the overall tetramerization of the M2 proton
channel, however they stabilize different accessible conformations of the
26

channel.42 If a single conformation is considered, stabilizing mutations are rare
and small in magnitude. Also, several mutations stabilize the integrin αIIb TM
homodimer but each is predicted to stabilize a non-native conformation.43
Therefore, if we calculate that a neutral mutation is stabilizing, the conformation
may be accessible, however it is likely not native.

Thus strongly stabilizing

mutations are penalized in our method, and they indeed help discriminate the
native fold from alternately folded conformations.
We calibrated our penalization functions with the well-characterized TM
helix dimer from glycophorin A. It is possible that the parameters we developed
are most useful at predicting GPA-like structures.

However, our protocol

identified a conformation that is different from the GPA conformation for two TM
helices in tetraspanin CD9.44 Additionally, it identified both GPA-like and nonGPA-like structures for the integrin αIIb/β3 TM heterodimer.45 Furthermore, it can
distinguish between different subtypes of GXXXG motifs.43 Each of the above
proteins contains one or more glycine-containing motifs which rely on geometric
complementarity and potentially Cα-H•••O hydrogen bonds for stabilization, and
our methods might prove especially useful at predicting these types of
interactions. Clearly, it would be desirable to include additional energetic terms
to allow the scoring of hydrogen bonding interactions, electrostatics, rotamer
strain, and other features that are important for association. We chose, however,
to use a simple energy function to analyze its performance in combination with
mutagenesis data. We demonstrated that a simple energy function is sufficient to
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predict the association of TM helix dimers when used in combination with
mutagenesis data. A more sophisticated energy function may be necessary for
the accurate prediction of more complex interactions.
Qualitative thermodynamics information was sufficient to generate
reasonable models for TM helix dimers, however quantitative information may
increase structure prediction accuracy for larger proteins. For example, each
disruptive mutant could be weighted proportionally to its experimentally
determined degree of destabilization.

A weighting coefficient could then be

applied to the disruptive penalty to scale its magnitude for different mutations.
However the penalties can be parameterized any number of ways to allow the
addition of quantitative thermodynamics information.

Molecular Model of BNIP3
BNIP3 is a “BH3-only” member of the Bcl-2 family of apoptosis factors. When
localized to the mitochondrial membrane, BNIP3 inhibits anti-apoptotic proteins
which otherwise block pore formation.46 Through this mechanism BNIP3 permits
the release of mitochondrial contents causing cell death. The function of BNIP3
homodimerization remains unknown, however its tremendous stability suggests
that its function requires a dimeric conformation.27
The BNIP3 TM dimer is more stable than the prototypical TM dimer
glycophorin A.

Sulistijo et. al predicted that concurrent AXXXG and GXXXG

motifs stabilize the BNIP3 homodimer in addition to electrostatic interactions
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involving His173, and site directed mutagenesis corroborated their hypothesis.27
Our model confirmed that the AXXXG and GXXXG motifs are at the homodimer
interface and predicted an interchain hydrogen bond between His173 and
Ser172. Following the publication of our model, the BNIP3 NMR structure was
released and the two conformations have a Cα RMSD of 1.06 Å, validating the
model, and more importantly, the modeling method.33

Conclusion
We developed a novel molecular modeling protocol that selects modeled protein
conformations based on experimental mutagenesis results.

In contrast to

modeling protocols that enforce distance or angular restraints, we examine the
relative stabilities for an ensemble of point mutations for each modeled
conformation and create a selective advantage for conformations that are
consistent with experimental findings. This approach is sufficient to identify the
native conformations of the glycophorin A and BNIP3 TM dimers without a
sophisticated force field or an exhaustive search through conformational space.
Importantly, the methodology was independently validated by the BNIP3 NMR
structure.
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CHAPTER 3

Multiple Approaches Converge on the Structure of the
Integrin αIIb/β3 Transmembrane Heterodimer

INTRODUCTION
Integrins, the principal cell surface receptors responsible for linking the
cytoskeleton to the extracellular matrix, are transmembrane (TM) heterodimers
composed of non-covalently associated α and β subunits. Integrin molecules
exist in an equilibrium between resting conformations that do not bind
extracellular ligands and active conformations that both engage ligands and
nucleate large intracellular complexes.1;

2

Agonist-induced intracellular signals

shift integrins from resting to active conformations by exposing extracellular
ligand-binding sites. To do so, signals must be transmitted across the membrane
via the integrin’s TM domain: an integrin is constrained in a resting conformation
by the heteromeric association of its α and β subunits’ TM domains. Moreover,
disruption of this association is sufficient to induce integrin activation (figure 7).3; 4
Thus, the α/β TM heterodimer is a critical structure in regulating integrin function.
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Fig 7. Integrins exist in equilibrium between resting and active conformations. In the
resting conformation, the integrin’s TM helices form an α/β heterodimer and the
cytosolic domains are held in proximity. In the active conformation, the TM and
cytosolic domains separate.

One of the most widely studied examples of regulated integrin function is
the platelet integrin αIIbβ3. In its active conformation, αIIbβ3 binds fibrinogen,
von Willebrand factor, or fibronectin and mediates platelet aggregation when
these αIIbβ3-bound ligands crosslink adjacent platelets.5

To prevent the

deleterious formation of intravascular platelet aggregates, αIIbβ3 is maintained in
a resting conformation on circulating platelets. Following vascular injury, αIIbβ3
is rapidly activated, enabling it to mediate the formation of a hemostatic platelet
plug. The formation and disruption of the αIIb/β3 TM domain heterodimer are
key events in shifting αIIbβ3 between resting and active conformations. Thus,
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there has been considerable effort to produce three-dimensional structural
models of the TM domain heterodimer.6; 7; 8; 9; 10 However, each published model
is substantially different and none have accounted well for the consequences of
introducing mutations into the αIIb and β3 TM domains. Because of the absence
of a satisfactory model for the αIIb/β3 TM heterodimer, we explored two new and
fundamentally different strategies to predict its structure.
In the first strategy, we utilized the Monte Carlo algorithm described in
Chapter 2.11 In the second strategy, we used a threading approach in which the
sequences of the αIIb and β3 TM domains were threaded onto a set of TM
dimers parsed from high resolution structures in the protein data bank. Threaded
structures were then scored according to their calculated energy and their
agreement with experimental cysteine crosslinking results. Although the Monte
Carlo and threading strategies relied on different sets of empirical data, they
converged on a similar structure that likely approximates the native conformation
of the αIIb/β3 TM heterodimer.

MATERIALS AND METHODS
Mutations used in the Monte Carlo Modeling Algorithm
We first modeled the αIIb/β3 TM domain heterodimer using the Monte Carlobased structure prediction strategy described in Chapter 2.11 The αIIb mutants
Val969Asn, Leu970Asn, Leu974Asn, Gly975Asn, Leu983Ala and β3 mutants
Ser699Asn, Val700Asn, Gly702Asn, Ile704Asn, Leu705Asn were scored as

39

neutral mutations, and the αIIb mutants Gly972Asn, Gly972Ala, Gly972Leu,
Gly976Leu and β3 mutants Met701Asn and Gly708Asn were scored as
disruptive mutations.2; 3

αIIb

I966WWVL VGVLG GLLLL TILVL AMW988

β3

I693LV VLLSV MGAIL LIGLA ALLIW715

Fig 8. Sequences of the αIIb and β3 TM domains. Amino acids are highlighted if one
or more of its mutants activate the integrin.

Comparing the Monte Carlo Interface with Other Published Structures
In order to sample every accessible dimer interface, our Monte Carlo method
considers interfaces that are similar to those in published structures and
theoretical interfaces that may not occur in nature. To assess whether the Monte
Carlo model might reflect a natural interface, Cα RMSDs were calculated
between the model and conformations found in high resolution crystal structures
from the orientations of proteins in membranes (OPM) database.12 Of the parallel
helix dimers parsed from OPM structures, 28% (113 of 400) had Cα RMSDs less
than 1.5 Å with the Monte Carlo model over at least ten residues from both the
αIIb and β3 helices which demonstrates that the Monte Carlo interface frequently
occurs in nature.
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Threading Known Structures with the Integrin’s Sequence
Threading is the modeling of an unknown structure based on the experimentally
determined structures of other proteins.13;

14

While it is usually applied to

problems in which the protein of unknown structure has a sequence that is highly
similar to a protein of known structure, we thought it could be useful for the
prediction of membrane helix pairs due to the limited number of packing motifs
found between membrane helices.15 The αIIb amino acids Ile966-Trp988 and β3
amino acids Ile693-Trp715 were threaded through 214 parallel TM helix dimers
parsed from pdbs 1c3w, 1e12, 1ehk, 1eul, 1fx8, 1h2s, 1iwg, 1j4n, 1jb0, 1k4c,
1kb9, 1kf6, 1kpl, 1kqf, 1l7v, 1l9h, 1m3x, 1m56, 1msl, 1nek, 1ocr, 1okc, 1pp9,
1pv6, 1pw4, 1q16, 1q90, 1qla, 1rc2, 1rh5, 1u7g, 1xfh, and 1yew, and the Monte
Carlo model was threaded as an internal control. Sequences were threaded in
all possible frames such that at least fifteen αIIb amino acids and fifteen β3
amino acids overlapped at the same depth in the membrane. If the integrin
sequence was longer than the template helix, only the portion of sequence for
which a three-dimensional template was available was evaluated.

When the

template was longer than the integrin sequence, the additional amino acids were
mutated to alanine to eliminate favorable contacts from the parent structure while
maintaining a penalty for steric clashes.

This procedure generated >50,000

models.
Each model was optimized prior to energy calculation: the side chain
rotamers of each structure were selected with the SCWRL3 algorithm,16 then
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each model was energy minimized in NAMD using the CHARMM force field.17; 18
NAMD minimization consisted of 2000 conjugant-gradient steps with a R=10
dielectric constant. Dimerization energies were calculated using the potential
function described in Chapter 2, where a dimerization energy is defined as the
energy of the optimized model minus the energy of the model’s helices separated
by 100 Å and re-optimized. The 500 lowest energy models were filtered based
on whether they were consistent with experimental cysteine crosslinking results.
Disulfide bonds crosslink αIIb-β3 amino acid pairs Gly972-Leu697,
Gly972-Val700, Val969-Val696, Val971-Leu697, and Trp968-Val696 when the
pair is mutated to cysteine.19 Accordingly, the distance between the Cβ atoms of
each pair was calculated to determine whether a model was consistent with
these results. Gly972 was mutated to alanine to add its Cβ atom, and any Cβ-Cβ
distance closer than 4 Å was set to 4 Å because this distance approaches the
maximum yield for cysteine crosslinking. Of the 500 low energy models, a “best”
model was selected that has the shortest average distance for the five αIIb-β3
residue pairs. It consists of a template from the 1iwg pdb for the crystal structure
of bacterial multidrug efflux transporter AcrB20 in which the αIIb TM amino acids
Trp967-Trp988 were threaded onto 1iwg chain A residues 392-413, and the β3
TM amino acids Ile693-Ala711 were threaded onto 1iwg chain A residues 466484.

The helices in this model were analyzed by HELANAL to characterize

deviations from ideal structure and calculate interhelix crossing angles.21 Other
cysteine mutant pairs have been analyzed in addition to the five robust
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crosslinking pairs considered here, and these datapoints were saved for structure
validation (below).19

Correlation with Cysteine Crosslinking Experiments
The Monte Carlo model, threaded model, and other published models were
analyzed to determine whether they were consistent with the cysteine
crosslinking experiments of Luo et al. that examined 120 αIIb-β3 cysteine mutant
pairs to determine the extent to which they could crosslink the αIIb and β3
subunits.19 Cysteine mutant pairs that are efficient at crosslinking the integrin
should be close in space relative to pairs that are less efficient at crosslinking,
and the distances between residues in a model should correlate with published
cysteine crosslinking efficiency.

We correlated different models with cysteine

crosslinking results as follows: for each cysteine mutant pair, the disulfide bond
formation efficiency was calculated by sampling its published color density in
Adobe Photoshop CS. Next, the distance between the Cβ atoms of each pair
was calculated for a given model. Glycine was mutated to alanine to add its Cβ
atom.

A plot of the Cβ distance versus cysteine crosslinking efficiency was

analyzed according to equation 4 using a non-linear least squares fitting routine
implemented in KaleidaGraph. This formula relates the percent yield (Yi,j) of the
disulfide between the i and j residues in a given double mutant to the distance
between their Cβ atoms di,j in a given model.
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Yi,j = Ymax *

!

1

4

# d i, j " 4.0 & n
1+ %
(
$ d 0.5 " 4.0 '

in which Ymax is the maximal yield observed for the protein of interest (generally
slightly less than 1.0 due to competing side reactions), (di,j – 4.0) reflects the
distance between the Cβ atoms with their van der Waals radii subtracted, and
(d0.5 – 4.0) reflects the distance at which crosslinking is approximately 50%. The
value of n reflects the fact that the crosslinking generally has a high order
dependence on the distance. Finally a correlation coefficient was calculated for
each fit to measure the accuracy of a given model.

Correlation with Mutagenesis Experiments
The Monte Carlo model, threaded model, and other published models were
analyzed to determine whether they are consistent with published mutagenesis
results.

TM mutations that activate the integrin cause the αIIb/β3 TM

heterodimer to separate, and these positions are likely to reside at the
heterodimer interface.2; 3; 10; 22 To determine whether a residue is at a model’s
interface, we calculated its fractional change in solvent accessibility in the model
and in the model’s separated helices. First, the solvent accessibility of each
amino acid was calculated using DSSP.23 Then the solvent accessibility was
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recalculated for the separated helices.

The fractional change in solvent

accessibility, fasa,i was calculated with equation 5

" model
%
ASA,i
fASA,i = 1 - $
'
# monomerASA,i &

!

5

in which modelASA,i is the solvent accessible surface area of the ith residue in a
model, and monomerASA,i is the solvent accessibility of the same residue when the
model’s helices are isolated.24 The fASA measurement was then correlated with
experimental mutagenesis results using linear regression. For this analysis, a
residue was assigned a value of 1 if at least one of its mutants activates the
integrin. These positions should reside at the heterodimer interface and have
fractional changes in solvent accessibility that approach 1. Other positions that
have been probed by mutagenesis were valued 0.

These positions should

cluster away from the heterodimer interface and have fractional changes in
solvent accessibility that approach zero. Mutations to hydrophilic amino acids
were disregarded because they can affect oligomerization and orientation in a
membrane, and mutations to threonine were disregarded because threonine can
perturb the secondary structure of a helix.25; 26 In summary, a model’s calculated
fASA values were correlated with a binary index of positions that can activate the
integrin when mutated.

45

Assessment of the Putative Arg995-Asp723 Salt Bridge
Reciprocal mutagenesis suggests that an interaction between αIIb Arg995 and
β3 Asp723 stabilizes the integrin’s resting state.27 The αIIb and β3 helices in the
Monte Carlo and threaded models were extended to Arg995 and Asp723 using
ideal backbone geometries (φ = -65º; ϕ = -40º; ω = 180º) and the feasibility of a
salt bridge was assessed by the manual manipulation of the Arg995 and Asp723
χ angles.

Arg995 and Asp723 were proximal in both the Monte Carlo and

threaded models, but only the threaded model allowed for the formation of a
Arg995-Asp723 salt bridge.

RESULTS
Monte Carlo αIIb/β3 Model
In the Monte Carlo-based algorithm, two straight helices consisting of αIIb amino
acids Ile966-Trp988 and β3 amino acids Ile693-Trp715 were docked by randomly
altering the six orthogonal parameters that orient two cylinders in space.11 The
algorithm’s scoring function was designed to favor conformations that were
consistent with published mutagenesis experiments by including a selective
advantage for disruptive mutations having higher energies than the wild type and
for neutral mutations that are iso-energetic. Inclusion of mutagenesis information
compensates for approximations made during energy calculations and the limited
conformational space accessible to the search algorithm.28 This strategy enabled
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us to accurately predict the structures of the TM homodimers for glycophorin A
and BNIP3 (see Chapter 2).11; 29
When applied to αIIb and β3, the Monte Carlo-based algorithm converged
on a structure with an angle of 18º between the two helical axes and a righthanded orientation (figure 9).

This type of interaction occurs frequently in

membrane proteins,15 and its conformation is similar to >100 different TM dimer
interfaces reported in the protein data bank (see Methods). The heterodimer
interface for αIIb consisted of residues Trp968, Val969, Gly972, Gly976, Leu980,
Leu983, and Met987 and the β3 interface consisted of Ile693, Val696, Leu697,
Val700, Met701, Ile704, Gly708, Leu712, and Trp715.

This structure is

consistent with a published cysteine crosslinking analysis that examined 120
possible pairwise interactions in the αIIbβ3 TM region, even though cysteine
crosslinking data was not considered in the modeling procedure (figures 10 and
12).19 The structure is also consistent with mutational analyses of the αIIb and β3
TM domains with the exception of mutations involving αIIb residue Thr981 that
activate αIIbβ3 expressed in tissue culture cells, but reside on the opposite side
of the αIIb helix from other activating mutations.2; 3; 10; 22
In addition to a TM heterodimer, αIIbβ3 function is thought to be
constrained by a “clasp” involving membrane-proximal portions of the αIIb and β3
cytoplasmic domains, a notable feature of which is a salt-bridge between Arg995
in αIIb and Asp723 in β3.27 Several previous NMR models of the αIIb and β3
cytoplasmic domains predict that Arg995 and Asp723 reside in helices, implying
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that the αIIb and β3 TM helices might extend into the cytosol, at least through
Arg995 and Asp723.30;

31; 32; 33; 34

When our Monte Carlo-derived model is

propagated into the cytosol with straight helices, the distance between the
Arg995 and Asp723 Cβ atoms is 12 Å, too far to form a salt bridge, however
perturbations from uniform helical structure might allow for an Arg995-Asp723
interaction.

Fig 9. The Monte Carlo model of the αIIb/β3 TM heterodimer. On the left, the αIIb
helix is depicted as a surface representation (red) and the β3 helix is shown as a stick
representation (cyan). Mutagenesis indicates that Gly972, Gly976, and Leu980 (blue)
reside at the heterodimer interface. On the right, the β3 helix is depicted as a surface
representation (blue). Mutagenesis indicates that Gly708 (red) is at the heterodimer
interface.
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Fig 10. Slices through the Monte Carlo model with amino acids highlighted (yellow)
that have a strong propensity to form a disulfide bond when the pair is mutated to
cysteine. Leu697 lies between its crosslinking partners Val971 and Gly972. Gly972 lies
between its crosslinking partners Leu697 and Val700. Finally, Val696 lies between its
crosslinking partners Trp968 and Val969.

Threaded αIIb/β3 Model
To verify the Monte Carlo structure, we used threading as a different approach to
derive a model for the αIIb/β3 TM heterodimer. In contrast with the Monte Carlobased methods, threading makes use of experimentally determined structures,
sampling real protein conformations rather than theoretical geometries. Thus,
threaded models can account for kinks, bends, coiling, and other deviations from
ideal helical structure with physically accessible conformations.
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We threaded the αIIb and β3 TM sequences through 214 parallel TM helix
dimers found in high-resolution crystal structures. The sequences were threaded
in multiple different frames to generate >50,000 structures. Each conformation
was optimized by SCWRL3.016 followed by 2000 conjugant-gradient steps in
NAMD,17 and their dimerization energies were calculated. The top 1% lowest
energy structures were analyzed to determine whether they were consistent with
cysteine crosslinking results, which complements the use of mutagenesis results
in the Monte Carlo strategy. Specifically, the distance was measured between
the Cβ atoms of five αIIb-β3 residue pairs having a high propensity to form a
disulfide bond when the pair is mutated to cysteine.19

(The remaining 115

experimentally evaluated cysteine mutant pairs were saved for structure
validation, see below).

The structure with the most consistent average Cβ

distance came from the 1iwg pdb of the crystal structure for the bacterial
multidrug efflux transporter AcrB20 consisting of αIIb Trp967-Trp988 threaded on
chain A residues 392-414 and β3 Ile693-Ala711 threaded on chain A residues
466-484.
As was the case for the Monte Carlo model, the threaded model has a
right-handed crossing. However, due to the non-linearity of natural helical axes,
the interhelix crossing angles in the threaded model range from 48º in the heart
of the GXXXG interface to 3.5º near its C-terminus. The steepest crossing angle
(48º) occurs between αIIb residues Gly972-Gly975 and β3 residues Ser699Gly702, and this conformation is characteristic of a canonical GXXXG interaction,
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which is a dimerization motif found in TM helices.15; 35; 36; 37 While the β3 helix is
relatively straight, the αIIb helix is kinked by 35º between residues Gly975 and
Gly976 which extends the αIIb-β3 interface beyond the GXXXG motif and permits
interactions near the membrane-cytosol boundary. Additionally, when the TM
helices were propagated into the cytosol, the structure allowed for an interaction
characteristic of the putative Arg995-Asp723 salt bridge.

The αIIb interface

consisted of residues Trp968, Val969, Gly972, Gly976, Leu980, Leu983, and
Met987 and the β3 interface consisted of Ile693, Val696, Leu697, Val700,
Met701, Ile704, and Gly708, essentially identical to the Monte Carlo model and
consistent with both mutational analyses and the additional cysteine crosslinking
pairs that were not used to score the model (figures 11 and 12). Finally, the Cα
RMSD between the Monte Carlo and threaded models is 1.3 Å indicating similar
structure.

Correlation with Experimental Results
The Monte Carlo and threaded models and other published models were
correlated with experimental mutagenesis and cysteine crosslinking results. Four
three-dimensional models have been previously reported for the αIIb/β3 TM
heterodimer at atomic level resolution. Two of the models were generated by
Monte Carlo methods that did not take into account experimental data (literature
models A and B).10

The other two models were generated from molecular

dynamics simulations of integrin homologs that converged on two conformations,
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TABLE III. Comparison of αIIb/β3 TM models
agreement with empirical data
model
M
T
A
B
1
2
disulfides
+++ +++
+
++
+++
mutagenesis
++
+++
++
+
++
salt bridge
+
+
Model similarity, Cα RMSD in Å
M
T
A
B
1
2
1.3
*
*
2.4
1.1
1.3
*
*
2.4
1.6
*
*
*
*
*
*
*
*
*
*
2.4
2.4
*
*
2.3
1.1
1.6
*
*
2.3

model
Monte Carlo
Threading
Model A
Model B
Model 1
Model 2
10
reference
* denotes a Cα RMSD greater than 3 Å

10

9

9

TABLE III.. A qualitative analysis of the Monte Carlo model, the threaded model, and
four published models. The Monte Carlo and threaded models are most consistent with
experimental results. “Disulfides” indicates whether a model is consistent with published
cysteine crosslinking results, “mutagenesis” indicates whether a model is consistent with
published mutational analyses, and “salt bridge” indicates whether a model is consistent
with the putative Arg995-Asp723 interaction. Quantitative analyses are shown in figures
11 and 12. Additionally, the structural similarity of each model is reported as Cα atom
root mean squared deviations in angstroms (RMSD). A RMSD of 0 would indicate that
two models are identical and a RMSD less than 2 indicates that two models are similar.
The Monte Carlo model, threaded model, and literature model 2 are structurally similar.

with representative structures reported for αIIbβ3 (literature models 1 and 2).9
Additional models of the αIIb/β3 TM heterodimer have been reported but were
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not considered here because they did not include atomic coordinates38 or contain
a number of D-amino acids.6; 7; 8
First, we considered how well each model correlates with the
consequences of mutating either the αIIb or the β3 TM domain, focusing on
mutations that induce constitutive αIIbβ3 activation and thus are likely present in
the heterodimer interface.

The fractional change in solvent accessibility was

correlated with experimental mutagenesis results as shown in figure 11. For this
analysis, residues were assigned a value of 1 if at least one of its mutants
activates the integrin (large green bar; missing bars indicate points for which data
is not available). These positions should reside at the heterodimer interface and
have fractional changes in solvent accessibility that approach 1 (peaks in red for
αIIb, blue for β3). Mutations with no significant effect on activation were valued 0
(small green bar). These positions should cluster away from the heterodimer
interface and have fractional changes in solvent accessibility that approach zero
(red/blue minima).

Disruptive mutations that occur at a model’s heterodimer

interface are marked with a “+” and indicate positive correlation.

We also

computed a correlation coefficient, R, for each model (figure 11), although we
note that a perfectly correlating model would not have an R=1 because the
mutagenesis results were treated in a binary manner. An example of a poorly
correlating structure is literature model B, which displays poor overall correlation
between fasa,i and experimental mutagenesis results (R = 0.06). The Monte Carlo
and threaded models have the best correlation coefficients (R = 0.46 and 0.57).
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Fig 11. Point mutations can activate the integrin (large green bars) or have no effect
(small green bars; missing bars indicate positions for which mutagenesis information is
not available). Activating mutations are likely to reside at the αIIb/β3 heterodimer
interface. The interface of each model was defined using a calculation based on each
amino acid’s solvent accessible surface (red and blue lines, see equation 5). A model is
consistent with experimental mutagenesis results if each activating mutation (large green
bar) occurs at the model’s interface (large change in solvent accessible surface).
Experimental mutagenesis results were correlated with the fractional change in solvent
accessible surface using linear regression, and each correlation coefficient R is reported.

Overall, the Monte Carlo and threaded models correlated with experimental
mutagenesis results while other models correlated to a lesser extent, or not at all.
Next, the models were correlated with the results of introducing disulfide
crosslinks between the αIIb and β3 TM domains. Luo et al. expressed full length
αIIbβ3 in 293T cells with single cysteine replacements in both the αIIb and β3 TM
helices and measured the efficiency of disulfide bond formation, based on the
premise that positions forming disulfide crosslinks should be closer in space than
positions that do not crosslink the integrin.19 Thus, the distance between the Cβ
atoms of two cysteine residues in a model were correlated with the
experimentally determined crosslinking efficiency for the pair (figure 12). For a
quantitative comparison, it would be ideal to obtain the rates of the crosslinking
reaction under carefully controlled conditions.
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Also, in comparing the

Fig 12. When single cysteine point mutations are introduced into both the αIIb and β3
TM helices, a disulfide bond can crosslink the integrin subunits. Cysteine crosslinking
yield correlates with the distance between two cysteines, and these distances can be
measured in a given model. Cβ distances for cysteine mutant pairs was plotted against
the experimentally observed cysteine crosslinking yield and fit to equation 4.
correlation coefficient of each fit is reported as R.

56

The

experimental data to computational models, it would be ideal to consider not only
interatomic distances, but also the angular relationship between Cα–Cβ bond
vectors and the local dynamics of the structure.39 However, even in the absence
of this information, a modest correlation can be observed between the extent of
disulfide formation and the distance between the interacting residues.40
The Cβ distances in the Monte Carlo model correlate well with the
cysteine crosslinking data (R = 0.82); furthermore, the equation 4 parameters of
d0.5 = 7.8 Å and n = 4 are consistent with values reported in the literature.39 A
similar good correlation was observed for the threaded model (R = 0.77; d0.5 = 7.7
Å; n = 3.1), and for literature model 2 (R = 0.73; d0.5 = 8.5 Å; n = 3.4). A less
good correlation was observed for literature model 1 (R = 0.56; d0.5 = 6.9 Å; n =
1.6), and a poor correlation was observed for literature models A and B.

DISCUSSION AND CONCLUSIONS
Although it has not yet been possible to determine the complete integrin structure
at high resolution, partial structural information has been derived from
mutagenesis,2; 3; 10; 22;

27

crosslinking,19; 41; 42;

43; 44

FRET experiments,4; 45 electron

microscopy,44; 46; 47; 48 crystallographic and NMR analyses of integrin fragments,30;
31; 32; 33; 34; 49; 50; 51; 52; 53; 54

and molecular modeling.6; 7; 8; 9; 10 Notably, the extracellular

portions of the integrins αvβ3 and αIIbβ3 have been crystallized in conformations
that are believed to represent their resting and active states.49; 50; 52 Additionally,
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NMR has been used to obtain structures of peptides corresponding to the
individual αIIb and β3 TM domains,53;
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individual cytosolic domains,30;

complexes between the αIIb and β3 cytosolic domains.31;

33; 55

34

and

However the

experimental determination of structures for a TM heterodimer has proven to be
challenging. Here, we describe two fundamentally different modeling approaches
that converged on the same structure for the αIIb/β3 TM heterodimer.

This

conformation differs from previously published models and favorably compares
with experimental data.

Review of Published Integrin TM Heterodimer Models
Gottschalk et al. performed the first structural analysis of the integrin TM
heterodimer using a grid/molecular dynamics protocol pioneered by Axel
Brunger.7; 56; 57 αIIbβ3 was modeled in parallel with homologous integrins in order
to identify an evolutionarily conserved structure. Twelve different conformations
were identified and a right-handed structure with a small crossing angle was
judged to be in best qualitative agreement with the then-available experimental
data. Subsequently, Gottschalk and Kessler modeled a portion of the αIIb/β3 TM
heterodimer via a molecular dynamics simulation that utilized interchain distance
restraints derived from NMR and an additional restraint imposed for the putative
Arg995-Asp723 salt bridge.8 These simulations converged on a single structure
that is consistent with a right-handed coiled coil. Recently, Gottschalk modeled
the αIIb/β3 TM heterodimer with a simulated annealing protocol that utilized
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distance restraints extrapolated from a cysteine crosslinking analysis and an
additional restraint for the Arg995-Asp723 salt bridge.6 This method converged
on a single conformation consistent with a right-handed coiled coil. However,
Gottschalk’s models contain a number of D-amino acids, possibly because of
unfavorable contacts in the starting coordinates, so the resultant models contain
a number of inverted stereo-centers.
On the basis of reconstructed electron cryomicroscopy images for low
affinity αIIbβ3, Adair and Yeager proposed that the TM domains of resting αIIbβ3
form a coiled coil and modeled it as either a left-handed or a right-handed
heterodimer by placing the Arg995-Asp723 salt bridge at the interface.38 They
noted that the right-handed coiled coil positioned more conserved amino acids at
the heterodimer interface; however these models were not considered in this
analysis.
Substantially different structures were proposed by Partridge et al.10 Four
hundred conformations were generated by Monte Carlo and representative
structures were selected from two heavily populated clusters that passed
geometric filters (literature models A and B). One of the conformations predicted
the effect of subsequent point mutations (model A).
Finally, Lin and coworkers performed a grid search of conformational
space followed by molecular dynamics for each grid point using the sequences of
each human integrin homolog in order to identify an evolutionarily conserved
structure.9 This method is similar to the original work of Gottschalk et al, however

59

proper chirality was maintained. Two conformations were identified (literature
models 1 and 2) and model 2 was predicted to reflect the resting αIIb/β3 TM
heterodimer.
Previously, we published a model of the integrin TM heterodimer using a
Monte Carlo strategy that included a selective advantage for conformations that
were consistent with experimental mutagenesis results, using an earlier
generation of the Monte Carlo software described in Chapter 2.2 In our original
publication, we were able to identify the same interface reported here, but were
unable to distinguish models with “shallow” interhelix crossing angles (-18º) from
those with “glycophorin-like” crossing angles (-40º).

We have since re-

parameterized the scoring function11 and the revised protocol consistently
identifies structures with a crossing angle around -18º.

Finally, this chapter

describes an additional threading method used to generate a model that is
consistent with experimental cysteine crosslinking results. The resulting model is
essentially identical to the Monte Carlo model, except it introduces a slight kink in
the αIIb subunit which allows for a larger crossing angle near the GXXXG
interface, similar to a canonical, glycophorin-like interaction.

Analysis of Different Models
An accurate model successfully predicts experimental results, and each
published model of the αIlb/β3 TM heterodimer is buttressed by one or more
empirical findings; however, each model has substantially different structure.
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Fig 13. (a) The αIIb helices of each model were aligned and a single αIIb helix is
displayed as a gray ribbon. Models have similar αIIb interfaces if their β3 helices
overlap (cylinders). (b) The β3 helices of each model were aligned and a single β3 helix
is displayed as a gray ribbon. Models have similar β3 interfaces if their αIIb helices
overlap (cylinders). (c) Alignment of the Monte Carlo model, the threaded model, and a
previously published model (literature model 2). These models have similar structure.
Residues Gly972, Gly976, Leu980, and Gly708 are highlighted in red.
Mutagenesis indicates that these residues are at the αIIb/β3 heterodimer interface. The
models are color coded as follows: Monte Carlo model, red; threaded model, orange;
model A, purple; model B, blue; model 1, green; model 2, yellow.

To quantitatively assess the accuracy with which a model predicts experimental
results, we performed objective measurements on each model and correlated
these measurements with published experimental findings.

First, fractional

changes in solvent accessibility were correlated with published experimental
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mutagenesis results; the Monte Carlo and threaded models reported here had
the highest correlation coefficients. Additionally, the distance between different
αIIb and β3 residues was correlated with published cysteine crosslinking results;
again the Monte Carlo and threaded models had the highest correlation
coefficients. Of the other models, literature model 2 had the strongest correlation
with experimental results and this model was structurally similar to the Monte
Carlo and threaded models with Cα RMSDs of 1.1 and 1.6 Å, respectively. It is
noteworthy that model 2 was generated by a molecular dynamics method
fundamentally different from the Monte Carlo and threading methods, and
selected models based on integrin homology rather than functional or
crosslinking data.9

Comparison with Models in Press
There are currently two additional models of the αIIb/β3 TM heterodimer in press
including a NMR structure55 and a model generated by the Rosetta algorithm
using restraints derived from experimental cysteine crosslinking results. Of the
models considered here, the Monte Carlo and threaded models are most
consistent with the NMR structure with RMSDs of 1.2 and 1.3 Å, respectively.
The Rosetta model has divergent structure that is more similar to the NMR
structure of glycophorin A than the models reported here.
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Table IV. Structural comparison of top performing models and models in press
Monte Carlo Threading
Model 2
NMR
Rosetta
Monte Carlo
1.3
1.1
1.2
1.9
Threading
1.3
1.6
1.3
1.4
Model 2
1.1
1.6
1.5
2.3
NMR
1.2
1.3
1.5
1.7
Rosetta
1.9
1.4
2.3
1.7
9
55
58
Reference
values correspond to Cα RMSDs in Å

Conclusion
We generated two models of the αIIb/β3 TM domain heterodimer using
fundamentally different methods:

a Monte Carlo algorithm that selected

conformations based on their agreement with published mutagenesis results and
a threading method that selected conformations based on their agreement with
cysteine crosslinking results. The two methods converged on a similar structure,
and when compared to previously published models, the Monte Carlo and
threaded models were most consistent with reported experimental findings,
suggesting they are most likely to reflect the native structure of the αIIb/β3 TM
heterodimer. These models have now been confirmed by its recently published
NMR structure.
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CHAPTER 4

Structural Characterization of a Disulfide-Linked αIIb/β3
Cytosolic Domain

INTRODUCTION
One of the widely studied examples of regulated integrin function is the platelet
fibrinogen receptor αIIbβ3.1 On a circulating platelet, αIIbβ3 is maintained in a
resting conformation to prevent deleterious interactions with other circulating cells
or the vascular endothelium that could cause thrombosis. Upon vascular injury,
platelets respond by activating αIIbβ3 to engage soluble ligands that crosslink
adjacent platelets and form a hemostatic platelet plug. The activation of resting
αIIbβ3 proceeds through intracellular “inside-out” signaling cascades that enable
the cytoskeletal proteins talin and kindlin-3 to bind the β3 cytosolic domain,
favoring conformations of β3 that displace αIIb from heteromeric αIIb/β3
interactions in the cytosolic and TM regions.2; 3 Separation of the TM heterodimer
transduces the intracellular activation signal across the membrane to expose the
integrin’s extracellular ligand-binding sites.4; 5 Active integrins can then nucleate
large complexes that initiate “outside-in” signaling cascades including the
activation of Src kinase which constitutively binds the β3 cytosolic domain.6
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The β3 cytosolic domain interacts with αIIb, talin, kindlin-3 and Src kinase,
and the structural basis of these interactions has been previously probed by NMR
and crystallography.7;

8; 9; 10; 11; 12

Each three-dimensional structure is markedly

different and it is unclear the extent to which differences reflect discrete
conformational states or different average structures from a dynamic equilibrium.
In either case, portions of both the αIIb and β3 cytosolic domains are dynamic,13;
14; 15; 16

a functional necessity for interactions with multiple different partners, and

small changes in experimental conditions might shift the dynamic equilibrium
between different conformations.
Despite their differences, the N-terminal portion of each β3 structure
contains a helix that extends to approximately Asp723, and analyses that include
the β3 TM domain depict this region as an extension of the TM helix.7; 8; 9; 10; 12; 14; 15;
16

This portion of β3 is important for stabilizing the integrin’s resting state,

including a putative salt bridge between β3 Asp723 and αIIb Arg995.17
Downstream of Asp723, published three-dimensional models have divergent
structure, including regions of β3 that interact with talin, kindlin-3, and Src
kinase.7; 8; 9; 10; 11; 15 These regions are dynamic, which might account for structural
differences between various models.14; 15; 16 Similarly, the αIIb cytosolic domain is
dynamic,13;

16

which might account for differences between its published

conformations.7; 8; 9; 12; 13; 18
The structural analysis of the αIIb/β3 cytosolic heterodimer is challenging
because of its dynamics and because peptides corresponding to the αIIb and β3
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cytosolic domains do not form a stable complex. Never-the-less, NMR structures
of the αIIb/β3 cytosolic interaction have been solved for heteromeric interactions
observed in equilibrium with other states.8;

9; 12

Notably, Vinogradova et al

developed a NMR model for the monomeric αIIb and β3 cytosolic domains
docked using 13 distance restraints derived predominantly from transferred
NOEs.8 More recently, Lau et al developed a NMR model of the αIIb/β3 TM and
membrane proximal regions that agrees with many empirical findings, including
mutagenesis of residues in the TM and cytosolic regions.12 This structure does
not form a stable complex, rather it interchanges between heteromeric and
monomeric states, similar to the equilibrium observed for the full length integrin.
However, the overlapping regions in the Vinogradova and Lau structures are
substantially different and vary from other reported conformations.8; 9; 12
Because published NMR models of the αIIb/β3 cytosolic interaction have
not converged on similar structures in part because the αIIb/β3 interaction is not
stable, we built a stable αIIb/β3 heterodimer by positioning a disulfide bond in the
αIIb/β3 interface (figure 14). This strategy was previously employed to study the
resting integrin’s αIIb and β3 cytosolic domains, however no interaction was
observed.16 Since these first generation constructs, we published a model of the
αIIb/β3 TM heterodimer19 that has been validated by experiments in several
subsequent reports.

Notably the model was confirmed by cysteine scanning

mutagenesis near the TM heterodimer’s N-terminus in which cysteine mutations
at the model’s interface could crosslink the αIIb and β3 subunits in the full length
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Fig 14.

Design of the disulfide-linked αIIb/β3 cytosolic heterodimer.

(top) The

sequences of the αIIb and β3 subunits; each subunit includes a SPE helix cap followed by
the cysteine C used for crosslinking. After the cysteine, the αIIb and β3 cytosolic
domains consist of residues W715-E1008 and L713-T762, respectively. Additionally,
the β3 subunit contained an upstream histidine tag that was used during purification
steps. The cysteines were positioned based on the αIIb/β3 interface depicted in the
Monte Carlo model from Chapter 3. (bottom) A cartoon depicting the position of the
engineered disulfide bond and its relation to other integrin domains including the αIIb
Arg995-β3 Asp723 salt bridge, which is postulated to stabilize the integrin’s resting
conformation, and β3 cytosolic domains that bind talin, kindlin-3, and Src kinase.
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integrin.20 Building upon this finding, cysteines were positioned in the model’s Cterminal interface, which is closer to the cytosolic domains, to crosslink a NMR
construct consisting of the αIIb and β3 cytosolic domains. The disulfide bond
enforces 1:1 stoichiometry and eliminates many conformations that are
inaccessible to the native integrin.
The construct was dissolved in dodecyl phosphocholine (DPC) micelles to
mimic the membrane environment and analyzed at 37º with physiological
protonation (pH = 6.0). The αIIb and β3 subunits had different circular dichroism
(CD) spectra before and after reducing the cysteine crosslink which
demonstrates that they interact when constrained by a disulfide bond.

The

analysis of chemical shift suggests that β3 interacts with αIIb along the face of a
helix containing β3 residues Lys716, Ile719, and Asp723, similar to the published
structure of the αIIb/β3 TM heterodimer.

However there were no NOE

interactions between αIIb and β3 downstream of the disulfide bond, the αIIb
subunit had no unique conformation, and the αIIb interface could not be defined.
Taken together, these results suggest a physical yet likely disordered interaction
between a β3 helix and a natively unstructured region of αIIb.
The β3 solution structure was solved with the disulfide-linked αIIb subunit
to enforce the conformation it has in the resting integrin. The structure consists
of an N-terminal helix and two additional cytosolic helices, similar to the solution
structure of the monomeric β3 TM and cytosolic regions.15 Portions of the β3
interfaces that bind talin had conformations that are similar to those observed in
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structures of β3/talin complexes,10; 11 suggesting that the β3 cytosolic domain is
pre-organized to bind talin. In contrast, the β3 NPXY motif that binds kindlin-3
resides in an α-helix, inconsistent with known interacting conformations for NPXY
motifs. However this helix was highly dynamic and its NPXY motif contained a
number of violated NOEs indicating the helical conformation exists in equilibrium
with other states. Lastly, Src kinase constitutively binds the last three residues of
the β3 cytosolic domain RGT,6 and this region was found to be unstructured and
dynamic, possibly primed for interactions with Src.
Finally, different portions of the β3 structure were analyzed with a
membrane insertion potential to define their calculated membrane embedding.21
The N-terminal helix embedded in a membrane spanning orientation, as
expected for a TM helix, and the two cytosolic helices partitioned into the
membrane/cytosol interface, suggesting amphiphilic character. Notably, the two
cytosolic helices contain residues that interact with talin and kindlin-3, and
membrane embedding can compete with these interactions. Thus the calculated
membrane embedding of the β3 structure defines conformations of the resting
integrin that are inaccessible to either talin or kindlin-3.

MATERIALS AND METHODS
Plasmid Constructs
The αIIb cytosolic domain was cloned into a pET-16b vector (Novagen) as a Cterminal fusion with the designed protein α3D, a small, highly stable protein that
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expresses well in bacteria.22 A linking region was engineered to include proline
to disrupt secondary structure, two glycines as a flexible spacer, and a thrombin
cleavage site.

The αIIb construct immediately followed including a SPE N-

terminal helix cap and the cysteine used to crosslink the αIIb and β3 subunits.

α3D-P-GG-LVPR-SPE-C-WKVGFFKRNRPPL

The construct’s sequence is:

EEDDEEGE. The italicized residues were used for expression, purification, and
crosslinking while the non-italicized sequence corresponds to αIIb residues
Trp988-Glu1008.
The β3 cytosolic domain was cloned into the pET-15b vector (Novagen) as
a C-terminal fusion to a histidine tag. This construct also includes a SPE Nterminal helix cap followed by the cysteine used for crosslinking the αIIb and β3
subunits. The sequence of the β3 peptide is: MGSSHHHHHHSSGLVPRGSHM-

SPE-C-LIWKLLITIHDRKEFAKFEEERARAKWDTANNPLYKEATSTFTNITYRGT.
The italicized residues were used for expression, purification, and crosslinking
while the non-italicized sequence corresponds to β3 residues Leu713-Thr761.
All constructs were confirmed by DNA sequencing.

Expression and Purification
The α3D-αIIb fusion protein was expressed in E. coli strain BL21. Cells were
grown to an OD600 of 0.8 AU in M9 minimal media supplemented with 200 µg/ml
Ampicillin, then induced with 1 mM IPTG for four hours at 37ºC. The media
contained

13

C glucose and/or

15

N ammonium chloride to label the peptide for
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NMR experiments. The cells were pelleted, resuspended in 50ml PBS per liter
culture, and lysed with three freeze-thaw cycles. Lysozyme was added to 100 µg
per ml and the lysate was sonicated to further break apart the bacterial
membrane. The cell debris was pelletted and discarded. The supernatant was
heated to 70º C for 30 minutes to denature soluble proteins, then cooled to 4º C
which precipitates denatured proteins while leaving the α3D-αIIb fusion protein in
solution.

The mixture was centrifuged to remove the precipitate and the

supernatant was dialyzed into PBS buffer at pH 7.5. Absorbance at 280nm was
used to approximate the protein concentration, and the fusion protein was
cleaved overnight with 10 units of thrombin per milligram protein. The cleaved
peptide was reduced with excess TCEP and further purified by reverse phase
HPLC. Finally, the eluted protein was lyophilized and stored at -80ºC. This
protocol generates >10mg of the αIIb cytosolic domain per liter culture. The
product’s molecular weight was confirmed by mass spectroscopy.
Likewise, the β3 peptide was expressed in E. coli strain BL21. The cells
were grown to an OD600 of 0.8 AU in M9 minimal media supplemented with 200
µg/ml Ampicillin then induced with 1 mM IPTG for four hours at 37ºC. The media
contained

13

C glucose and/or

NMR experiments.

15

N ammonium chloride to label the peptide for

The β3 peptide was purified on Ni-NTA resin using the

QIAExpressionist protocol for denaturing conditions (Qiagen). Eluted β3 peptide
was reduced with excess TCEP and further purified by reverse phase HPLC.
Purified β3 was lyophilized and stored at -80ºC.
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The histidine tag was not

removed from the β3 cytosolic domain, and this protocol makes 10mg of the β3
construct per liter culture. The product’s molecular weight was confirmed by
mass spectroscopy.

Coupling αIIb and β3
The β3 peptide was dissolved at 5mg/ml in 2M guanidine, buffered to pH 6.0 with
50mM MES. The reduced β3 cysteine thiol was activated for coupling with 5-fold
molar excess 2-2'dithio-bis-(5-nitropyridine) dissolved DMSO.23 Activated β3 was
purified from excess 2-2'dithio-bis-(5-nitropyridine) on a PD-10 column using 5%
acetic acid as the mobile phase.

The purified β3-thio-nitropyridine was

lyophilized. Activated β3 was reacted with a slight molar excess of reduced αIIb
in guanidine-MES buffer, pH 6.5 for several hours.

Crosslinked αIIbβ3 was

purified from the reaction mix using reverse phase HPLC and the eluted protein
was lyophilized. The heterodimer’s molecular weight was confirmed by mass
spectroscopy.

Circular Dichroism (CD) Spectroscopy
CD spectra of 10µM disulfide-linked αIIb/β3 heterodimer in 5mM sodium
phosphate buffer containing 10mM DPC, pH 6.5 was recorded in a 1mm path
length cell before and after the addition of the reducing agent TCEP. TCEP was
added from a 0.5mM stock solution, pH 6.5 at 5-fold molar excess. As a control,
buffer without reducing agent was added to a similar sample.
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αIIb/β3
β3
αIIb
αIIbβ3 + reducing agent

protein standard
crosslinked αIIb/β3

Fig 15. SDS-PAGE analysis of a NMR sample, crosslinked αIIb/β3, and the same
sample with the addition of reducing agent. The NMR sample has a molecular weight
that corresponds to αIIb/β3, and it is composed of subunits with molecular weights that
correspond to the individual αIIb and β3 peptides. Samples were further validated using
a battery of more rigorous techniques including mass spectroscopy.

NMR Spectroscopy
The disulfide linked αIIbβ3 heterodimer, as isolated from HPLC, was dissolved at
1mM in 5mM sodium phosphate buffer containing 100mM perdeuterated dodecyl
phosphocholine (DPC, Cambridge Isotope Laboratories), 10% deuterium oxide,
and 0.02% sodium azide as a preservative. The pH was adjusted to 6.0 with
sodium hydroxide. DSS was added to some samples at 1mM to reference proton
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chemical shifts.

Samples were analyzed at 37ºC on a 750 MHz NMR

spectrophotometer equipped with a Varian probe.

A standard battery of

experiments allowed us to identify the proton, carbon, and nitrogen resonances
for most backbone, aliphatic, phenyl, phenol, indole, imidazole, amide, and
guanidinium groups.24

β3 Structure Calculation
NOE distance restraints were derived from a 3D 15N-editied NOESY, 3D aliphatic
13

C-edited NOESY, 3D aromatic 13C-edited NOESY, and a 4D 13C-edited NOESY.

Hydrogen bonding distance and geometry restraints25 were implemented for the
backbone amides of β3 residues Leu713-Ile721 which are protected from
hydrogen-deuterium exchange and predicted to reside in an α-helix. Additionally,
the φ and ψ dihedrals of β3 residues Ile714-His722, Phe727-Arg736, and Tyr747Ile757 were restrained based on the statistical analysis of chemical shift using
the TALOS algorithm26 which predicts that these regions are helical. For other
residues, chemical shift restraints were implemented for their Cα and Cβ atoms,27
and chemical shift restraints were implemented for every Hα atoms.28 Finally,
HN-Hα J-couplings were measured in the HNHA experiment and implemented as
φ dihedral angle restraints for helical regions or J-coupling restraints for regions
with less defined secondary structure which restricts the φ dihedral to 1-4
possible angles.29
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6000 structures were calculated with XPLOR-NIH using a protocol similar
to the anneal.py example script that comes with the software package.30; 31 The
top 60 structures were refined using the same protocol with increased weighting
for proper bond geometries. The top 20 refined structures were aligned over
residues Leu713-Ala735, which converged on a similar conformation, and this
structural ensemble will be submitted to the protein databank upon publication.

Hydrogen-deuterium exchange (HDX)
HDX was performed by re-dissolving a lyophilized NMR sample in deuterium
oxide.

Exchange was monitored in the

15

N HSQC experiment and the first

timepoint was available at 11 minutes.

Calculated Membrane Insertion
β3 residues 713-735 and 744-762 from the calculated structure were embedded
in the membrane using a grid search that sampled membrane depth and two
orthogonal rotations. Energies were calculated using the E(z) potential,32 and the
conformations with the best E(z) energies are depicted in figure 22.

RESULTS
Design of the disulfide-linked αIIb and β3 cytosolic domains
The NMR construct was engineered to enforce the interface observed in the
Monte Carlo model from Chapter 3. Specifically, the TM residues Met987 in αIIb
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and Leu712 in β3 occur at the model’s interface and these positions were
substituted with cysteine to crosslink the NMR construct (figure 14).19 The model
predicts an ideal disulfide bond between the two cysteines, and the disulfide
bond contains three torsional angles that can accommodate conformational
adjustment and dynamics. The subsequent NMR structure of the αIIb/β3 TM
heterodimer confirmed this model and that Met987 and Leu712 occur at the
αIIb/β3 TM interface.12
Additionally, N-terminal SPE helix caps were added upstream of each
cysteine to enforce helical structure that might be propagated from the TM
helices to the cytosolic domains. The N-terminal portion of the β3 subunit was
helical, however, the αIIb subunit had no stable secondary structure, consistent
with the conformations observed in two recent NMR analyses of the αIIb and β3
TM and membrane proximal regions in phospholipid bicelles.13;

14

Finally, the

construct was characterized with a histidine tag attached to the N-terminus of β3
which was used in purification steps.

Circular dichroism spectroscopy demonstrates that the αIIb and β3
cytosolic domains interact
We first used circular dichroism (CD) spectroscopy to determine whether
crosslinking the αIIb and β3 cytosolic domains affects their structure. The CD
spectrum of disulfide-linked αIIb/β3 was dominated by signals at 190, 208, and
222 nm which is characteristic of helical secondary structure (figure 16). When
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the disulfide bond was reduced, these signals had smaller magnitudes which
suggests the disulfide-linked heterodimer has more helical content than its
component monomers. The different CD spectra demonstrate that αIIb and β3
interact when constrained by the engineered disulfide bond.

molar ellipticity

Fig 16. The circular dichroism (CD) spectrum of the disulfide-linked αIIb/β3 cytosolic
heterodimer (solid line) was dominated by signals at 190, 208, and 222 nm, characteristic
of helical secondary structure. When the αIIb and β3 subunits were separated by
reducing the disulfide bond, the monomers had a different CD spectrum (dotted line)
which demonstrates that αIIb and β3 interact when constrained by the disulfide bond, and
that this interaction affects their structure.

Cα chemical shift indicates that crosslinking the αIIb cytosolic domain to
β3 induces conformational changes in the β3 subunit
To further probe the interaction between αIIb and β3, we identified differences in
Cα chemical shift between the disulfide-linked αIIb/β3 heterodimer and a
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previously characterized β3 monomer. Cα chemical shift is an NMR parameter
that is sensitive to protein secondary structure and protein interactions.33 Prior
analysis of Cα chemical shift found that this parameter demarcated three helical
regions in a construct consisting of the monomeric β3 TM and cytosolic
domains.15 Similarly, this parameter demarcates three helical regions of β3 in the
disulfide-linked αIIb/β3 heterodimer (figure 17). However, there were significant
differences in Cα chemical shift between the β3 monomer and the αIIb/β3
heterodimer encompassing twelve residues that define the N-terminal β3 helix in
the heterodimer construct. This region includes residues that are considerably
downstream of the disulfide bond and demonstrates that the disulfide bond
enforces other cytosolic αIIb/β3 interactions. Lastly, the Cα chemical shifts of
αIIb displayed no preference for helical secondary structure, consistent with a
recent NMR structure of this region that includes its neighboring TM domain
embedded in phospholipid bicelles.13

Aliphatic chemical shifts define a β3 interface that interacts with αIIb
The β3 interface that interacts with αIIb was identified by comparing the

13

C

HSQC spectra of the disulfide-linked αIIb/β3 heterodimer and the reduced
monomers. Reducing the disulfide bond altered side chain chemical shifts in β3
residues Lys716 and Ile719 which indicates that these residues interact with αIIb
(figure 18).

This interface resides on a face of the N-terminal β3 helix that

includes Asp723 (figure 21), consistent with predictions that Asp723 is at the
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αIIb/β3 interface.17 Additionally, it is consistent with the β3 interfaces reported in
previous NMR structures of the αIIb/β3 cytosolic interaction including the
structure of the αIIb/β3 TM heterodimer that found 7 NOEs between Ile719 and
different αIIb residues.8; 9; 12

Fig 17. Cα resonance is an NMR parameter that is sensitive to protein secondary
structure and protein interactions. This parameter demarcated three helical regions of β3
in the disulfide-linked heterodimer, similar to a previous structural analysis of the β3
monomer; helices end when the Cα resonance approach its random coil value (Cα
resonance – Cα random coil = 0). The αIIb subunit affects Cα resonances over the first
twelve residues of β3 in the disulfide-linked construct, suggesting that the disulfide bond
enforces additional interactions in this region.
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Fig 18. Side chain chemical shifts are sensitive to protein interactions, and the chemical
shifts of aliphatic atoms can be visualized in the

13

C HSQC spectrum. The blue and

purple signals correspond to aliphatic atoms in the disulfide-linked αIIb/β3 heterodimer,
and the red and green overlay corresponds to the αIIb and β3 monomers. The chemical
shifts of β3 residues Lys716 and Ile719 change when the disulfide bond is reduced which
suggests these residues interact with αIIb. (Purple and green signal is folded in the
carbon dimension by 20 ppm).

Analysis of NOEs at the αIIb/β3 heterodimer interface
The analysis of aliphatic chemical shifts demonstrates that β3 residues Lys716
and Ile719 interact with αIIb, however these residues displayed no interchain
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NOEs with αIIb. Furthermore, the only NOEs between the αIIb and β3 subunits
occur near the disulfide crosslink. Upon first inspection, this result appears to
conflict with published NMR structures that found NOEs between the αIIb and β3
subunits.

These analyses relied on innovative strategies to detect interchain

NOEs, including transferred NOE experiments8 and selective labeling,12 because
the heterodimer could not be isolated from conformations that otherwise masked
αIIb/β3 interactions. However our experimental design effectively isolates the
heterodimer by positioning a covalent tether at its interface. In this construct, a
stable interface would be readily defined by standard NOE experiments, and we
employed a 4D NOESY that can unambiguously identify NOEs including every
interchain NOE observed in the published structure of the αIIb/β3 TM
heterodimer.12 The lack of interchain NOEs at the β3 interface suggests that the
αIIb/β3 cytosolic interaction is intrinsically disordered, at least in the disulfidelinked construct described here.
Also, the guanidine group of αIIb Arg995 is postulated to form a salt bridge
with β3 Asp723,17 and our experimental conditions allowed us to unambiguously
assign guanidine resonances (figure 20) and detect NOEs between the guanidine
groups and other adjacent protons. However the Arg995 guanidine protons did
not have any NOEs with the β3 sidechain. This result is consistent with an
intrinsically disordered interface, and the interaction likely reflects a solvent
exposed acid/base pair that does not have a unique conformation, but could still
impart some specificity between the αIIb and β3 subunits.34; 35
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Fig 19. The H-15N NOE intensity correlates with backbone dynamics. β3 residues
Leu713-Glu726 and αIIb residues Val990-Asn996 undergo similar dynamics which
suggests that these regions interact. Downstream residues are increasingly dynamic,
including two β3 helices. Additionally, the β3 RGT motif is dynamic which suggests it
is accessible to cytosolic proteins.

Backbone dynamics are consistent with an αIIb/β3 interaction
Since there were no NOEs between the αIIb and β3 subunits, suggesting an
intrinsically disordered interaction, we determined whether the construct’s
dynamics were consistent with an αIIb/β3 interaction. The strength of the H-15N
NOE correlates with each residue’s order parameter and it was analyzed to
qualitatively assess the dynamics of the disulfide-linked construct.36; 37 The αIIb
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residues Val990-Asn996 and β3 residues Leu713-Glu726 have similar H-15N
NOE intensities which supports our finding that these regions interact (figure 19).
However, the αIIb intensities trended toward higher dynamics, consistent with a
natively unstructured region of αIIb interacting with a structured, helical portion of
β3. Residues downstream of this interacting region were increasingly dynamic in
both the αIIb and β3 subunits.

Stability of β3 secondary structure determined by hydrogen-deuterium
exchange
The increasing dynamics in β3 corresponds to increasingly divergent structure in
published models of β3, and since the β3 subunit in disulfide-linked αIIb/β3 is
predominantly helical, hydrogen-deuterium exchange (HDX) was used to
determine whether dynamics can account for differences in helical content. We
performed HDX by dissolving a lyophilized NMR sample in deuterium oxide and
identifying amide protons that do not exchange with deuterium, indicating they
are likely to form stable hydrogen bonds in a helix.

The first β3 helix was

protected from exchange which demonstrates it has stable helical structure
(figure 20).

In contrast, β3’s second two helices were not protected from

exchange which demonstrates they have transient helical structure.

These

results suggest that dynamics might account for differences between β3
structures reported in the literature which each depict an N-terminal helix, but
have varying degrees of helical content downstream of Asp723.
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Fig 20. The

15

N HSQC detects backbone amines, and in some cases, the arginine

guanidine group. When the αIIb/β3 heterodimer is transferred from water to deuterium
oxide, most of the protons exchange with deuterium but the red peaks corresponding to
β3 residues Ile714-Ile721 are protected from exchange which suggests they form stable
hydrogen bonds in a helix. In contrast, other helical regions exchange rapidly with
deuterium, suggesting they are dynamic.

β3 structure calculation
NMR structure calculations were used to further define the three-dimensional
conformations of αIIb and β3 based on NOEs, the statistical analysis of chemical
shift, and HN-Hα J-couplings.

However calculations did not converge on a

unique conformation for the αIIb subunit because it does not contain secondary
structure and has incompatible NOEs, presumably due to a dynamic equilibrium
between multiple conformations. Additionally, residual dipolar couplings (RDCs)
were measured for use as structural restraints, however they did not aid structure
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calculation in part because the structure is dynamic and the RDC alignment
tensors vary throughout the construct. This result is consistent with a natively
unstructured conformation for αIIb.
In contrast with αIIb, the β3 subunit contained NOE patterns that defined
three helical regions. Additionally, NOEs defined the orientation of the first two
helices in the construct. However many unambiguous NOEs are violated in the
calculated structure which define (1) alternate rotamer conformations, (2)
alternate conformations for the loop linking the last two helices, and (3) alternate
conformations for the NPXY motif that terminates the last helix. These violated
NOEs were identified in initial structure calculations and eliminated from the
calculations used for the structural ensemble presented here to reduce
contradictory energy gradients that might otherwise falsely restrain the structure.
The quality of the structural ensemble was assessed using PROCHECK-NMR38
and 86.8% of the residues have conformations in the “most favored” region of
Ramachandran space; a structure with ideal statistics has >90% but <100% of its
residues in the most favored region, and the β3 structural ensemble has near
ideal Ramachandran statistics when the loop regions are not considered.

The β3 cytosolic domain is primed for interactions with talin, kindlin-3, and
Src kinase
The structure and dynamics of β3 sequence motifs that interact with talin, kindlin3, and Src kinase were further analyzed to determine whether they could assume
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conformations that are compatible with binding (figure 21). First, motifs that bind
the cytoskeletal protein talin were compared to crystal and NMR structures that
depict β3/talin interactions.10; 11 Several β3 residues are critical for talin binding

Table V. Summary of the β3 structure statistics
NOE restraints
residue 1, 2
NOE classification number of NOEs
i to i
self
87
i to i+1
neighbor
355
i to i+2
turn/loop
57
i to i+3/4
helix
360
i to i>4
turn/loop
29
total
888
NOEs per residue
17.8
violations > 0.5 Å
1*
Dihedral angle restraints
TALOS φ/ϕ
HN-Hα φ
violations > 10º

30/30
16
0

Chemical shift restraints
Cα/Cβ
Hα

19/19
50

HN-Hα J coupling
restraints

11

Hydrogen bond O…H-N
distance restraints

5

Residues in most favored
regions of
86.8%
Ramachandran space
*107 NOEs were omitted from the structure calculation and
violated by the final structural ensemble.
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Fig 21. The β3 NMR structural ensemble was divided into two regions consisting of
residues Leu713-Trp739 and Asp740-Thr762 and the Cα atoms of each region were
aligned. Domains that interact with αIIb, talin, kindlin-3, and Src kinase are circled and
side chains that make up the interfaces are depicted as spheres. Also, the two β3 NPXY
motifs are colored brown and the RGT motif that binds Src kinase is colored
blue/green/red. Notably, the analysis of chemical shift suggests that Lys716 and Ile719
interact with αIIb, and these positions reside on the same face of a β3 helix as Asp723,
which is postulated to form a salt bridge with αIIb.

including Trp739 and a β3 NPXY motif consisting of residues Asn744, Pro745,
Leu746, and Tyr747.3;

11

Every Trp739 indole resonance was unambiguously

assigned and probed in 13C and 15N NOESY experiments edited for indole 13C/15N
frequencies.

Several protons displayed NOEs at the solvent resonance, but

there were few NOEs with other atoms in the construct. This lack of interaction is
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apparent in the structural ensemble and quite rare for a tryptophan indole,39
suggesting that Trp739 is both accessible and primed for interaction. Next, the
structure of the β3 NPXY motif that binds talin was defined by NOEs, the analysis
of chemical shift, and J-coupling which predict that the NPXY is a N-terminal helix
cap that nucleates an α-helix.

The N-terminal helix cap is similar to

conformations observed in previous structures of the β3/talin interaction,11
suggesting that the β3 NPXY motif pre-organized to bind talin, however the
capping interaction has never been described for an NPXY motif and will be
discussed in further detail below. Finally, a previous NMR analysis found that
talin interacts with a helical portion of β3 containing Phe727 and Phe730,10 and
this portion of β3 is helical in the structure presented here, suggestion that this
interface is pre-organized to bind talin as well.
The β3 interface that binds the cytoskeletal protein kindlin-3 has been
defined as a NPXY motif consisting of β3 residues Asn756, Ile757, Thr758, and
Tyr759 and possibly the upstream residue Ser752,2 although the kindlin-3
interface has not been as extensively examined as the talin interface and there
are no experimental structures depicting the interaction.

The kindlin-binding

NPXY motif terminates the final β3 helix in the structure presented here, which is
not a known interacting conformation.

However, this region of β3 is highly

dynamic and contains NOEs that are incompatible with a single conformation
which suggests that the NPXY motif exists in equilibrium between conformations
have different affinities for kindlin-3.
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Lastly Src kinase binds the last three C-terminal residues of β3 Arg760,
Gly761, and Thr762 which are called an RGT motif,6 although the structural basis
for this interaction has not been described in the literature. Our NMR analysis
found that the RGT motif is highly dynamic (figure 19), does not have a unique
conformation, and does not interact with other portions of the construct which
suggests it is accessible and primed for interactions with Src.

NOEs define the β3 NPXY Motif as a N-terminal Helix Cap
An NPXY motif consists of residues Asn-Pro-X-Tyr and this sequence binds
phosphotyrosine binding (PTB) domains upon phosphorylation (X can be any of
several different amino acids).40 Talin contains a novel PTB domain that binds
the unphosphorylated β3 NPXY motif consisting of residues Asn744, Pro745,
Leu746, and Tyr747. Previous structures of NPXY motifs found that they adopt a
type I β-turn when bound to a PTB domain, however the crystal structure of β3
bound to talin is consistent with both a type I β-turn and a N-terminal helix cap.11
In the NMR structure of the disulfide-linked αIIb/β3 heterodimer described here,
NOEs define a conformation that is most consistent with a N-terminal helix cap
that nucleates the second cytosolic helix in β3, suggesting the conformation of
the β3 NPXY motif is pre-organized to bind talin thereby minimizing its entropic
cost of binding (figure 23).
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Calculated membrane insertion predicts the regions of β3 that interact with
talin and kindlin-3 partition into the membrane.
The membrane embedding of the β3 subunit was calculated using a membrane
insertion potential.32

The N-terminal helix partitions into the bilayer in a

membrane spanning orientation which suggests it is an extension of the TM helix
(figure 22). Additionally, the two downstream helices partition into the membrane
in amphiphilic conformations, derived in part from hydrophobic residues Phe727
and Phe730 in one helix and Tyr747 in the other which also make up portions of
the interfaces that interact with talin.10; 11 Intriguingly, the membrane embedding
of these helices would sequester them from interactions with talin and kindlin-3.
This finding suggests that the β3 cytosolic domain exists in equilibrium between a
membrane bound conformations that cannot bind talin or kindlin-3 and
accessible, solvent exposed conformations.

DISCUSSION AND CONCLUSIONS
Previous NMR analyses hypothesized that the native αIIb/β3 interface would
stabilize a complex between peptides corresponding to their cytosolic and/or TM
domains, however a stable 1:1 complex has never been observed. Based on
these findings, a disulfide-linked αIIb/β3 cytosolic domain was engineered that
has 1:1 stochiometry and enforces an interface observed in models of the αIIb/β3
TM heterodimer. The αIIb and β3 cytosolic domains interact in the construct and
their interface is intrinsically disordered, consisting of a natively unstructured

99

region of αIIb interacting with a β3 helix. The structure on the β3 subunit was
calculated, and we further characterized β3 interfaces that interact with αIIb, talin,
kindlin-3, Src kinase, and the cell membrane.

Fig 22.

Portions of the calculated β3 structure were oriented using a membrane

insertion potential. The first helix in the β3 construct embedded in a membrane-spanning
orientation and two subsequent helices embedded in amphiphilic orientations.

The

membrane-embedding of Phe727, Phe730, and Tyr747 would prevent interactions with
talin and the membrane embedding of Tyr759 would prevent interactions with kindlin-3.

Prior analysis of the integrin cytosolic domains
The resting integrin’s cytosolic heterodimer has been probed by several NMR
analyses.8;

9; 16; 41

Notably, Vinogradova et al. observed transferred NOEs

between peptides corresponding to the integrin’s cytosolic domains and
calculated a structure based on these interactions.8

Several features of the

resting integrin support this model, however transferred NOEs require a
kinetically unstable interaction, so they are more likely to reflect non-specific
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interactions than the standard NMR experiments used for protein structure
determination.
Vinogradova’s research suggests that the integrin’s TM heterodimer is
necessary to stabilize the cytosolic heterodimer, and two strategies attempted to
account these interactions. First, Ulmer et al. engineered several constructs with
N-terminal disulfide bonds and coiled coils that fixed the αIIb and β3 cytosolic
domains in a parallel orientation with 1:1 stoichiometry, however no heteromeric
interaction was observed, suggesting that the αIIb and β3 cytosolic domains do
not interact or that the upstream constraints failed to approximate native
interactions.16 To account for native TM domain interactions, Li et al. analyzed
peptides containing both the cytosolic and TM domains of αIIb and β3, however
the peptides formed homo-oligomers instead of heterodimers.41 More recently,
Lau and coworkers found experimental conditions that favored heteromeric TM
associations and developed an NMR model for this interaction that agrees well
with mutagenesis results.12 However this analysis only considered a fraction of
the αIIb and β3 cytosolic domains and did not report on their dynamics.
We combined prior strategies to stabilize the αIIb/β3 heterodimer by
including a portion of the αIIb and β3 TM regions and introducing a disulfidecrosslink at the TM heterodimer interface.

This construct is the first stable

αIIb/β3 cytosolic heterodimer that has an observable αIIb/β3 interaction, and it
allowed us to define the structure and dynamics of the αIIb and β3 cytosolic
domains in a single conformation that approximates the integrin’s resting state.
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The αIIb/β3 cytosolic interface is intrinsically disordered
CD and NMR analyses revealed that the engineered disulfide-crosslink in the
αIIb and β3 TM region enforced an interaction between the αIIb and β3 cytosolic
domains. However while the chemical shift differences of the β3 Lys716 and
Ile719 side chains demonstrated that these residues interacted with αIIb, they
displayed no NOEs with αIIb suggesting the interaction is dynamic on the
millisecond timescale. Also, we found that the αIIb subunit had no stable helical
structure, consistent with a previous NMR structure of this region in
phospholipids bicelles.13 Never-the-less, αIIb interacted with β3 over the length
of approximately twelve residues including portions of the β3 helix that are
significantly downstream from the TM crosslink. The interaction suggests that
the αIIb subunit does not have random structure, instead it has conformational
bias toward structures that interact with β3. This type of intrinsically disordered
interaction is important for proteins that couple multiple different signaling events
to an overall equilibrium. For the integrin, an intrinsically disordered interface
allows it to couple many different cytosolic events to the overall resting-active
equilibrium.

The integrin’s equilibrium can be affected by talin and kindlin

binding,2; 3 phosphorylation,42 and proteolysis,43 and the cytosolic domains convert
this dynamic information into a binary signal: resting or active.
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The αIIb Arg995-β3 Asp723 salt bridge is a solvent exposed interaction
Mutations affecting cytosolic residues αIIb Arg995 and β3 Asp723 activate the
integrin, but reciprocal mutations Arg995Asp and Asp723Arg restore the
integrin’s resting state.17 This result is widely interpreted as evidence that a salt
bridge between Arg995 and Asp723 stabilizes the resting conformation. The
current analysis is consistent with the Arg995-Asp723 salt bridge and provides
some evidence supporting the interaction. First, Asp723 is at the β3 interface
that interacts with αIIb, and second, the regions that contain Arg995 and Asp723
undergo similar dynamics.

However, HDX suggests that Asp723 is solvent

exposed, so any interaction between Asp723 and Arg995 would be more similar
to an electrostatic interaction on the surface of a protein than a buried interaction
that might have a single stable conformation.

Solvent exposed electrostatic

interactions are dynamic and can be very important for specificity without locking
an acid/base pair into a single conformation.34;

35

This type of interaction is

especially useful for orienting a dynamic interface without providing a driving
force that could independently stabilize the αIIb/β3 complex.

The β3 NPXY motif is a N-terminal helix cap
Previous structures of NPXY motifs have been characterized as type I β-turns40
and have slightly different structure than the β3 NPXY motif which was found to
be a N-terminal helix cap that nucleates an α-helix. The capping conformation is
similar to previous structures of talin bound to β3, PIPKγ, and a β3/PIPKγ chimera
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that are consistent with both β-turns and N-terminal helix capping motifs,
however the NPXY motifs in these structures do not nucleate helices.10; 11; 44 It is
possible that talin binding favors unfolded conformations of the β3 helix, which
might function to expose the second NPXY motif to bind kindlin-3.

The membrane embedding of β3 prevents interactions with talin and
kindlin-3
The E(z) membrane depth potential predicts that the β3 cytosolic domain is
amphiphilic and residues Phe727, Phe730, and Tyr747 partition into the cell
membrane (figure 22), consistent with previous NMR experiments that observed
NOEs between DPC and Tyr747.7

Membrane insertion sequesters these

residues from cytosolic proteins so they cannot bind talin as depicted in
structures of the β3/talin complex, and the membrane embedding of the kindin-3
binding site would prevent β3 interactions with kindlin-3 as well. However the
cytosolic helices exist in dynamic equilibrium with unfolded states that likely
correspond with solvent exposed conformations.

Amphiphilic domains that

switch their degree of membrane exposure are commonly found proximal to TM
helices in proteins including voltage gated channels,45; 46 phospholamban,47 and
the M2 proton channel from influenza.48; 49 Recently, the cytosolic domain of the
T-cell receptor’s CD3ε subunit was found to bind membrane which sequesters
aromatic residues from cytosolic proteins including a tyrosine in its NPXY motif.50
When

the

T-cell

receptor

is

activated,
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the

amphiphilic

domain

is

Fig 23. Analysis of talin
binding to the β3 cytosolic
domain. (a) The analysis
of chemical shift suggests
that β3 residues Lys716
and Ile719 interact with
αIIb, and these residues lie
along the same face of the
β3

helix

Asp723,

that

includes

which

is

postulated to form a salt
bridge with αIIb residue
Arg995.

Also,

prior

structural analysis of β3 and talin depict interfaces that contain β3 residues Phe727,
Phe730, Trp739, and Tyr747. (b)

Talin interacts with a β3 NPXY motif, and the

calculated β3 structure suggests that the NPXY motif is a N-terminal helix cap that
nucleates an α-helix. (c and d) Talin (orange) cannot bind the β3 structure reported here
because it is amphiphilic and embeds in the membrane. When β3 is modeled as a helix,
similar to a previous NMR model that depicts a β3/talin interaction, the αIIb interface
resides on the same face of the β3 helix as the talin interface. These findings are
consistent with the hypothesis that talin shifts the integrin equilibrium toward active
conformations and displaces αIIb from heteromeric interactions with β3.
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released from the membrane and binds signaling proteins. The β3 cytosolic
domain might have analogous interactions with membrane where the cytosolic
domain favors a membrane associated conformation in the resting integrin and
talin and/or kindlin-3 shifts the conformation toward a solvent exposed state.

Talin binding to the β3 cytosolic domain requires a conformational change
The membrane embedding of the β3 cytosolic domain is partially mediated by a
kink near the membrane/cytosol interface. However, the kink adopts a helical
conformation in an NMR structure of the β3/talin complex which suggests the
kink straightens when β3 binds to talin.10 The helical conformation positions
Phe727 and Phe730 on the same face of the β3 helix as residues that interact
with αIIb (figure 23c and d), consistent with the hypothesis that talin displaces
αIIb from the β3 cytosolic domain.3

The β3 RGT motif is accessible to Src kinase
Integrin activation and clustering induces the autophosphorylation of Src kinase
which initiates intercellular signaling cascades.6 Src constitutively binds the β3
cytosolic domain and the β3 RGT motif is critical for this interaction. Although
most of the β3 cytosolic domain is membrane-embedded and inaccessible to
cytosolic proteins, the RGT motif is unstructured and should be accessible to Src.
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CONCLUSION
The NMR analysis of the disulfide-linked αIIb/β3 construct reveals that stable TM
interactions are coupled to an intrinsically disordered cytosolic interaction. This
structural organization allows the cytosolic domains to integrate many different
cytosolic events into a binary signal that activates the integrin or maintains its
resting state.
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CHAPTER 5

Discussion, Future Direction, and Concluding Remarks

DISCUSSION
The previous chapters describe the development of software used to model the
αIIb/β3 TM heterodimer, the verification of the model, and the use of the model to
engineer an NMR construct that approximates the conformation of the resting
integrin’s cytosolic domains. Considering first the construction, benchmarking,
and validation of modeling algorithms, an ideal structure prediction method would
require only a primary amino acid sequence to accurately calculate a protein’s
three-dimensional coordinates. However, as evidenced in the CASP competition,
currently no method can reliably predict a protein’s structure without additional
information from empirical analyses.1 Regardless, structure prediction is more of
an art than a science when it is not supported by experimentation, and so
prediction and experimentation go hand-in-hand. In chapter 2, we describe the
implementation of restraints that enforce calculated differences in energy
between a wild type model and the same model containing selected point
mutations in order to provide a selective advantage for conformations that are
consistent with experimental mutagenesis results.2 While it is unlikely that the
Monte Carlo algorithm will be employed in additional structure prediction efforts,
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the energy function and calibration methods provide a framework to implement
this new type of thermodynamic restraint in next generation protocols.
Next, chapter 3 provided a quantitative assessment for various models of
the αIIb/β3 TM heterodimer, and ultimately substantiated the Monte Carlo model.
This chapter provides strong corroboratory evidence in favor of the interface
reported in the Monte Carlo model, and recently published NMR and Rosetta
models likely mark the final global push to determine the αIIb/β3 TM
heterodimer’s structure with every major player agreeing to the consensus
model, declaring victory, and elevating the interface from hypothesis to dogma.3; 4
Still, several features of the αIIb/β3 heterodimer remain unresolved: First, the β3
TM domain contains a conserved SXXXA dimerization motif that is not involved
in the αIIb/β3 interaction (corresponding to a GXXXG dimerization motif in other
β subunits), and its function has not been discovered. Second, mutations to αIIb
Thr981 create a constitutively active state, but its role in stabilizing the resting
integrin remain unknown.5;

6

Lastly, although the structure of the αIIb GFFKR

motif converged on similar conformations in both the NMR and Rosetta models,3;
4

and the orientation of these residues agrees well with experimental results--and

makes good physiological sense--the interaction between this region of αIIb and
the β3 membrane proximal, cytosolic domain has not been defined at highresolution, and the significance of a possible αIIb Argg995-β3 Asp723 interaction
remains subject to debate.3; 4
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The solution structure of the β3 subunit in the disulfide-linked construct
sheds light on the membrane proximal αIIb/β3 interaction. Our analysis
demonstrates that the αIIb and β3 cytosolic domains interact and suggests a
specific interface for β3, consistent with the β3 interface defined by mutagenesis,
cystiene crosslinking, and multiple NMR models. In contrast, the literature record
has not reported a reproducible αIIb interface; instead our results suggest that
αIIb is natively unstructured, and the αIIb/β3 interface is intrinsically disordered.
This type of interaction may have evolved to couple multiple different intracellular
events to the binary resting/active signal relayed by the TM domains. Lastly, we
analyzed the structure the β3 cytoslic domain and calculated that helical
conformations of the talin and kindlin-3 binding sites partition into the membrane,
a topology that is inaccessible to either protein. Thus the binding of talin or
kindlin-3 would trap the β3 cytosolic domain in an exposed conformation,
providing a mechanism for conformational change that could shift the integrin
equilibrium toward an active state.

In conclusion, this thesis describes three-dimensional structures for the αIIb/β3
TM and cytosolic heterodimer. These models corroborate experimentally defined
αIIb/β3 interfaces and provide a foundation for new, testable hypotheses that
back avant-garde mechanisms of integrin activation.
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